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From the time of its first description by Laennec in
1806, malignant melanoma has been the subject of controversy
and dread. For nearly 100 years there was no firmly founded
policy of treatment. The first rational surgical attack was
described by EVE in 1902. SAMPSON HANDLE!, in the Hunterian
lectures of 1907» based on this tumour the further development
of his researches into the spread of malignant oells via
lymphatic pathways. Since they were conveniently marked
they traced their course from the primary site to the
draining nodes and a regime could be planned to deal with all
the expected treatable routes of spread. Handley confirmed
Eve's recommendation of prophylactic lymph node dissection
and described the en bloc operation which has been one of the
accepted therapeutic standbys since.
While the techniques of surgery became well established
quite early in this century, easily understandable and
significant survival rates were not published until the
third and fourth decades. These tended to oonfirm the
pessimistic description of the tumour as the most malignant
superficial neoplasm. Only one of BLOODGOOD's two hundred
cases survived five years (1922). With improvements in case
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selection, education of the general practitioner and the
public, and the realisation of the dangers of inadequate
therapy, the outlook improved through PACK's 9*6% 5 year
results (1947) to PANAYOTIS* 1962 series of 1?0 patients,
of Whom 42.35^ survived overall. Undoubtedly a higher
proportion of patients are reporting at an earlier stage
and surgeons are now treating all moles with respect. In
certain sites, in females with disease confined to the
skin, adequate excision has produced 5 year survival rates
of 70% (LAHE, LATTES and MALM; 1959). However in other
sites, particularly in males, apparently equivalent lesions
continue to cause the death of 4 patients out of 5 within
5 years and in some cases dissemination appears to follow
attempts at removal with great rapidity.
In Europe this clinioal impression was noted early and
recourse was made to newer and less well tried modes of
treatment. As early as 1903 Gassenbauer reported to the
Vienna Medical Society twenty cases of "melanotic sarcoma"
treated by exposure to radium, (reported by TRACEY, 1903).
More recent results of radiological management have claimed
ft
very high survival figures at the three year period (MULLER-
MIHY, 1955) but since biopsy is forbidden their publications
lack histological confirmation (HELLRIEGEL, 1952). In the
United Kingdom ELLIS (1939 and 1946) and TOD (1946) reported
93 and 21 oases respectively in which radiation was used.
Their results in early cases, usually combined with surgeiy,
were more than equal to those of surgery alone.
A combination of surgery and post-operative radiation
was found useful in Scandinavia (SCHARNAGEL, 1933* JORGSHOLM
and ENGDAHL, 1952* NITTER, 1958) although SYLVEN (1949) bad
doubts about its efficacy. DICKSON (1958) carried this
doctrine across the Atlantic. Preoperative radiation of the
primary and post-operative Xray therapy of the block dissected
nodes where these are involved is the current management in
Russia (MEL'NIKOV and FEDOREYEV, 1961). The doses however are
far higher than is acceptable in the West.
In America, COLEY reported regression in one or two
cases treated with Xrays in 1903» but by 1916 called this mode
of treatment "a most unwise procedure"• Although no large
series was produced to support the contention, malignant
melanoma rapidly gained the reputation of being the most
resistant neoplasm to radiation. Individual case reports
(OWEN, 1924) and small series (KEITH and KEITH, 19221
QUIGLEY, 1924) contested this view but others (MORROW and
TAUSSIG, 1924) reported complete failure. Cauterising doses
of Xrays were olaimed by EVANS and LEUCUTIA (1931) to have
produced good results but their Illustrations of early
primaries are open to other diagnostic interpretations of
a more benign nature. On this rather uncertain clinical
foundation statements are found in textbooks of dermatology
(ORMSBY and MONTGOMERY, 1954) surgery (EDWARDS, 1949)»
onoology (RAVEN, 1959) and radiotherapy (PORTMANH, 1950)
that radiation is contraindicated in the condition.
RALSTON PATERSON (1948) goes so far as to say that a
"malignant melanoma" which is locally cured by radiotherapy
is probably not a malignant melanoma.
Much of the early controversy surrounding malignant
melanoma lay in the field of hlstopathology. Unna, noting
the epidermal origin of the lesion, dubbed it a carcinoma
but RIBBERT (1897), basing his work on the morphology of
the established tumour, differed. He attributed the origin
of the "chromatophores" to the dermal histiocytes and defined
the neoplasm as a sarcoma. Later works by DAWSON (1925) end
ALLEN and SPITZ (1953) have clearly established the origin of
the malignant process in the basal layers of the epidermis
from the cell which is more correctly termed a melanoblast.
In addition they showed the relationship of the neoplasm to
the benign naevi which has been lucidly and succinctly
stated by HICKS, HANK and WAKEFIELD (1955). The derivation
of the melanoblast from the neural crest and its migration
to the peripheral epideimis are perhaps less clearly
understood but appear to be reasonably well founded on
comparative animal work (BECKER, 1948) and serial examinations
of foetal skin (ZIMMERMAN and BECKER, 1959). MASSON (1951)
has for many years propounded the dual origin of naevi from
cutaneous and nervous tissue based upon the staining
properties of the cells. Other Pathologists, principally
ALLEN have rejected this hypothesis and produced convincing
illustrations of fraying of the basal layers of the epidermis
into tumour tissue. It may be that Masson's neurogenic
theory has contributed to the stigma of radioresistance since
nervous tissue, particularly such a highly differentiated cell
functionally speaking as to continue producing pigment, was
thought to be almost immune to damage from ionising radiation.
DESJARDINS (1934) certainly classed the tumour among the least
radiosensitive sarcomata.
DAWSON's exhaustive study of the histogenesis of the
developing melanoma laid the foundation for ALLEN and SPITZ's
later description of the various grades of malignancy although
no reference is given in the later work to Dawson's
contribution. Although the more recent publication has been
widely accepted as differentiating between "junctional naevi,
active junctional naevi, superficial melanocarcinoma and
invasive melanoma" the separation of these from the so-called
juvenile melanomata is not universally acclaimed as explaining
the very different prognosis in childhood and post-pubertal
lesions. McWHQRTER's thesis (1954) does however tend to
confirm their findings and use has been made of their criteria
of distinction in seleoting the material for the present study.
The more recent pathological "staging" (it would have surely
been preferable to use the term "grading" since this is more
commonly applied to pathological material) introduced by
PETERSEN et al (1962), is perhaps more acceptable as a
universally applicable definition but in no way really differs
from Allen and Spitz's and as they have the prior claim their
terminology has been adopted.
The present series, comparing radiation and surgery, in
a very crude fashion, was made possible by the fact that the
primary treatment of pigmented tumours in Melbourne was for
many years in the hands of the radiotherapist. From 1928 when
the present case recording system started, until the late 1940'
many cases of melanotic neoplasms were referred in the
first instance to the Radium Department of the Royal
Melbourne Hospital. During this period surgexy became
increasingly popular so that by the time World War 11
finished and plastic techniques were introduced only
inoperable or recurrent cases were normally referred. With
the establishment in 1956 of a radiosurgical unit at the
Peter MacCallum Clinic which in the interim had supplanted
the Radium Department, a reversal of policy was oompleted so
that most treatable melanomata were subjected to operation.
This reversal of policy will be evident in the numbers
available for three, five and ten year assessment. Ho claim is
made that the cases analysed represent all the melanomata
presenting in Victoria or even Melbourne as many private
patients were operated on in other units and at least three
other teaohing hospitals and two other radiotherapeutio groups
were in operation.
Material
All cases registered as melanoma, malignant melanoma,
melanosarcoma or melanocarcinoma, at the Radium Department of
the Royal Melbourne Hospital and its successor the Peter
Table I
Discarded. Cases
Wrongly registered : actually lymphosarcoma. 1
No histology or convincing clinical description. 5
3 cases alive and well, 22, 22 and 15 years.
1 untraced, 3 years.
1 died aged 97> 16 years.
Sclerosing angioma. 2
2 alive and well, 10 and 1 years.
Juvenile melanoma (Allen and Spitz,1953; McWhorter, 1954)* 2
1 alive and well, 2 years.
1 untraced, 5 years.
Superficial melanocarcinoma (Allen and Spitz, 1953)* 8
8 alive and well, 10 years to 6 months __
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Table II
Cases Accepted as Malignant Melanoma Without Review of Histology.
Surgery alone. - 8
3 died of melanoma within 5 years.
3 died of melanoma, 5» 6 and 18 years.
2 died of other disease within 3 years.
Radiation first. 7
4 died of melanoma within 5 years.
1 died at 3 years, probably with disease.
1 discharged well and untraced after 5 years.
1 alive and well, 20 years.
All had convincing clinical descriptions and were implanted.
Surgery} recurrence} radiation. 6
3 died within 5 years of melanoma.
1 died of melanoma in the 7th year.
1 died of melanoma in the 9th year.
1 alive and well after repeated excisions and finally implant
10 years after first treatment.
Palliative therapy. 10
8 died of melanoma within 3 years.
1 died'of other causes at 4 months.
1 untraced at 2 years.
No Treatment.
2 died of melanoma, 3 years and 1 month*
2 untraced within 1 month.
4
8.
MacCallum Clinic up to December 1959 were reviewed. Of the
total number of 301, 6 were excluded as wrongly registered or
as having neither histology nor an adequate and convincing
clinical description and histoxy. 12 more were thought to be
sclerosing angioma, juvenile melanoma, or superficial melano-
carcinoma (Allen and Spitz) on reappraisal of the histology.
All remain alive and well at the completion of the series and
have been excluded from subsequent discussion. One case,
originally diagnosed as superficial melanocarcinoma was found
to be a true invasive melanoma and eventually died of melanoma.
This case has been included. (Table I).
Histology was not always available for reconsideration
in cases treated prior to 1955 and. in some cases had not been
examined at all. Reliance had therefore to be placed in a few
cases upon the original pathologist's opinion or a convincing
clinical description and history. Table II details the
proportion and fate of these patients in each treatment group.
The 283 cases remaining fell into 5 groups according to
the treatment they received. Many patients had already had
some fotm of treatment before referral. 11 were offered no
further treatment at the centre but were returned for more
radical surgery and did not report again, were in extremis or
Table III
No -effective Treatment Group
Age 25-35 36-45 46-55 56 - 65 66 - 75 76 - 85 86 - Unknown
12114011
3ex 6 males 5 females
Site Head and neck Arm Trunk Leg Foot Unknown (dodes only or
multiple)
1 12 14 2
Size (cm.) 0—1 1—2 2-3 3-4 4-5 5-6 6-7 7-8 8-9 Unknown
041102001 2
Stage and fata I II Til
2 referred back for excision and 1 untraced. I untraced.
untraoed. 1 locally excised only 3 died 1, 2, 3 died 1, 2,
but died 12 years later with and 36 months. and 4 months,
multiple metastases.
refused treatment. These are recorded separately in Table III
but are included in the overall basic data and survival rates.
Only palliative therapy was possible in 55 patients either by
reason of the extent of their disease or their age and general
condition. 88 received surgery alone or sUrgery and chemo¬
therapy for metastases. At no time was radiotherapy used so
that to this extent they form a selected group. Most were
referred to the Peter MacCallum Clinic after the establishment
of a combined radiosurgical skin clinic in 1956 and hence are
not available for survival studies. A further 47 cases were
primarily treated by radical surgery but received radiation
for recurrence or metastases. The remaining patients, 82 in
number, were originally treated by radiation in one form or
another, either alone or in combination with surgery. The
surgery in most cases consisted of local excision of any remnant
or radionecrosis following implant or Xray therapy. Post¬
operative radiation is included in this group where the
radiation was administered within 4 weeks of operation and formed
part of the planned regime.
Methods
In the treatment of the primary tumour, radiation most
frequently took the form of a radon needle implant deep to the
Table IV.
Sex of Gases
Surgery alone or with chemotherapy





lesion. A biopsy was often taken at the time of Insertion
of the needles. Soft Xrays from a Chaoul tube were used
when beds or sources were not available. The dosages used
were in the region of 6,000 roentgens at 0.5 cm in 4 to 7
days with implants and 3,000 to 5»000 roentgens on the surface
of the lesion in 10 to 15 sessions over 2 to 3 weeks with the
Chaoul tube. Any remnant or radioneorotic ulcer was excised
after a variable lapse of time up to several years after
treatment. In a few cases local excision of the lesion
usually by the referring General Practitioner was followed
either by X-irradiation or a radon mould delivering much the
same dosages.
Adequate surgery was deemed to have been performed if
wide excision had been carried out with margins ranging from
2.0cm. to 4.0cm. In most cases skin grafting was required.
Where the nodes lay adjacent an enbloc procedure was
performed.
Prophylactic treatment of the nodes was often omitted.
Block dissections were rare in the prewar period but became
routine after 1956. They were usually "delayed" where the
nodes lay remote from the primary area#
11.
Clinical lymphatic metastases were more frequently
excised than Irradiated and more frequently implanted than
treated externally. The numbers are small in both groups.
Results
Sex. There were 139 males and 144 females. This almost
equal division of the sexes held for all subdivisions except
the palliative where there were approximately twice as many
males as females (Table IV), This may reflect the more
advanced stage at which males presented.
Staging. Staging was determined according to the scheme
adopted by several authors. (SCHARNAGEL, 1933? STLVEN, 1949).
Stage li disease confined to the primary site on clinical
examination. Stage 111 palpable but operable nodes in the
immediate draining group present. Stage 111 J inoperable nodes
or distant metastases found on examination or Xray, Local
recurrences were staged as 1 if they conformed to the
definition given. Staging as 1, 11 or 111 applies to the
patient's condition at the time of the first visit to a
medical practitioner. This is modified in those cases who
subsequently had radiation by substages A, B or C corresponding
12.
to the same criteria hut defining the condition as at referral
for radiotherapy. Thus a patient whose melanoma was
primarily excised and who subsequently developed nodes which
were irradiated would he Stage IB if the nodes were operable
and IC if they were fixed or distant metastases were found.
Pathological findings do not alter the clinical staging as it
felt that the separation of oases should he on clinical
grounds alone if a different treatment policy is to he adopted
for different stages or a comparison is to he made between
procedures, one of which is not amenable to histological
confirmation of staging.
Survival. Ho attempt has been made to estimate "Cure
rates" (PACK, 1959) since this first> gives a false impression
of the value of treatment, second is inaccurate in that a not
inconsiderable proportion of patients succumb to disease after
apparent cure and third may impart a false sense of security in
the patient's and the practitioner's mind. The only clinically
observable and absolute fact about a patient is that he is alive
or dead. No conditional statements are necessary.
"Determinate oases" only are used in the survival rates
which are quoted (STLVEH, 1949). Cases lost to follow up or
dying of unrelated causes within the period under consideration
are omitted but are indioated in Table XIV under the end result
AGE DISTRIBUTION
Table V
0-15 16-23 36-45 46-53 56-65 66-73 76-83 86- ?
Surgery alone 0 4 10 22 19 13 ll 8 1 0
Radiation 0 9 12 20 12 12 12 4 1 0
Surgery; recurrence;
radiation 2 4 9 11 11 4 4 0 0 0
Palliative 1 5 11 7 12 3 9 6 1 0
No treatment 0 0 1 2 1 1 4 0 1 1
3 22 41 62 5? 33 42 18 4 1
Sable VI
Stage Age Sex and Survival.
Age Q - 15 1L=uS5 26 - .35 ^ 4ft - 5.5 5ft w 65 66-75
S«*. M F_Tot.,_ M P , Tot,, M T Tot, MF Totj, M _.JF . Tot, , M F. Tot,
Stage I 1/1 0 1/1 1/1 3/5 4/6 2/4 5/8 7/12 l/T^TlO 5/16 2/4 3/5 5/9 1/4 1/4 2/8 0/4 1/3 1/7
Stage II 0 0/1 0/1 1/2 1/1 2/3 1/1 1/2 2/3 1/2 0 1/2 0/4 o/l 0/5 0/1 0 0/l 0 0/1 0/1
Stage III 0/1 0 0/1 0/2 0 0/2 0/1 0 0/l 0/2 0/2 0/4 0 0/2 0/2 p/l 0 0/1 0/2 0/1 0/3
10 year
survivors 1/2 Q/1 1/3 2/5 A/6 6/11 3/6 6/l0 Q/16 2/10 Z/12 6/22 2/8 3/3 5/lft 1/ft 1/4 2/19 Q/ft 1/5 lZli
Stage I 1/1 0 1/1 4/6 5/6 9/12 3/5 9/12 12/17 4/1* 6/13 11/25 3/7 6/9 9/16 2/6 3/7 5/13 3/7 4/6 7/13
Stage II 0 0/1 0/1 1/2 1/2 2/4 1/1 2/3 3/4 2/6 O/l 2/7 0/5 0/3 0/8 O/l Q/t 0/2 l/t 0/l 1/2
Stage III 0/1 0 0/l 1/2 0 1/2 0/1 0 0/1 6/2 0/2 0/4 O/l 0/2 0/3 0/2 0 0/2 0/2 C/1 0/3
5 year
survivors 1/2 Q/1 1/3 ft/lQ 6/8 12/18 4/7 11/15 15/23 ft/3Q ft/16 13/36 3/1? ft/14 9/27 2/9 3/8 5/17 4/1Q 4/8—Z/U
Stage I 1/1 0 1/1 6/7 6/6 12/13 6/7 11/13 17/20 7/17 8/15 15/32 3/9 13/16 16/25 4/6 6/8 10/14 4/8 5/9 9/1?
Stage II 0 0/1 0/1 2/2 1/2 3/4 2/2 3/5 5/7 2/8 0/1 2/9 2/5 2/5 4/10 0/1 0/1 0/2 1/1 0/1 1/2
Stage ni 0/1 0 0/1 1/2 0 1/2 0/2 ' 0 0/2 l/3 1/2 2/5 0/2 1/2 1/4 0/2 0 0/2 0/4 0/l 0/5
3 year
survivors 1/2 0/1 1/? 9/11 7/8 16/1? 8/11 W18 22/29 10/28 9/18 19/46 5/lft 18/23 gl/39 4/9 6/9 1Q/18 5/19 S/11 10/2l
Less than 3 years
Stage I 0 0 0 0 1/1 1/1 3/4 2/3 5/7 3/4 8/8 11/12 1/3 6/6 7/9 3/3 7/9 10/12 1/3 2/3 3/6
Stage II 0 0 0 1/1 0 1/1 0 \/\ 1/1 o/l 0 q/l 3/3 1/1 UK 0 0 0 O/l 0/1 q/2
Stage III 0 0 0 0 0 0 C/1 0 0/l 0 0 0 o/l 0/l 0/2 0 0/1 0/l 2/3 0 2/3
Survivors o o o 1/1 i/i 2/2 3/5 3/4 8/9 3/5 8/8 11/1? 4/7 7/8 11/15 3/? 7/10 1Q/1? 3/7 2/4 5/1.
Dead of other disease
or untraced
000011 055 21 31 01 202 437
Grand total













































































Age, Star<s net Survival 0-35 36 —
Stage I 12/19 13/41
Stage II 4/7 1/9
Stage III 0/4 0/9
Ten year survival rate 16/30 14/59
Stage I 22/30 33/67
Stage II 5/9 3/20
Stage III 1/4 0/12
Five year survival rate 28/43 36/99
Stage I 3Q/34 57/96
Stage II 8/12 7/26
Stage III 1/5 3/16
Three year survival rate 39/51 67/138
13*
and In Table IX to allow assessment of the possible range of
survival* The overall survival rates are shown as a chec*' of
additions at the end of each table# For males the 3, 5» and 10
year survivals are 46 of 96 patients (48$), 28 of 72 (39?6) and
11 of 44 (2556). For females the figures are 60 of 93 (6436),
36 of 70 (51#), 19 of 45 (42*). The totals are 106 of I89
(56.2?6)# 64 of 142 (45.056) and 30 of 89 (33.756). These include
all determinate cases presenting at the centre. Survival is
dated from the first attempt at treatment whether this is
adequate or inadequate since no other means can be used to
gauge the natural history of the disease and compare this with
the effect of treatment. The result may be to inflate the survival
rates but the average delay between inadequate and adequate
treatment was less than 6 months* The trend towards better
survival for female cases tallies with that of most other
authors quoted but is not significant.
Age* Age distribution is shown in Table V and figure I*
The only deviation between sub groups is a not unexpected
preponderance of elderly patients in those who received
palliative therapy only. The survival rates are shown in
Table VI according to age, sex and stage. Table VII shows that
a difference between patients 35 years and under and 36 years














































































Site. Sex. Stage and Survival.
H?ad yid N?ck







3/12 7/11 10/23 43.5
1/5 0/2 1/7
0/3 0 0/3






































10/28 10/7 20/45 44t? 3/14 5/13 8/27 29,5







































Less than three yean
Stage I 8/13 9/11 17/24
Stage II 1/1 1/1 2/2





















9A5 10/13 19/28 6/8 1/S 7/13 2A 11/12 13/16












































































































































































Size. Sax. Stage and Survival.
Size (cm.) 0-1











Stage I 1/4 2/4 3/8
Stage II 0/1 0 0/1
Stage III 0/1 0/1 0/2
Ten year

























Stage I 3/8 8/11 11/19
Stage II 0/1 0 0/1
Stage III 0/1 0/1 0/2
Five year
survivors 3/10 8/12 11/22
























Stage I 7/10 13/13 20/23
Stage II 0/2 1/2 1/4
Stage III 0/1 1/2 1/3
Three year



























Stage I 3/4 9/10 12/14
Stage II 1/1 0 1/1
Stage III 0/1 0 0/1








































Total 22 28 ^ 42 47 82 17 18 35 7 3 10 11 10 21 40 38 28 Hi 144 ,222
14.
Site. All oases are divided as to site and sex in
Table VIII, There is a significant difference at the 0.1%
level of probability in the distribution of lower limb
primaries between the sexes. An opposite trend but not of
statistical significance can be seen in trunk primaries.
Table IX breaks down the survivors according to site, stage
and sex. It can be seen that trunk melanomata are more
advanced and have a lower survival rate than most other
sites. The difference between lower limb and foot primaries
is not significant for 3 and 5 year results but approaches it
(x * 4.4) at the ten year point.
Size. The effect of the size of the primary on the stage of
disease is more apparent in Table X than any effect upon the
survival rate, if equivalent stages are compared.
The Extent of the First Treatment. Effective treatment
was considered to be wide surgical excision, implantation of
radioactive sources deep to the lesion, or Xray therapy
administered under the direction of a radiotherapist.
Ineffective treatment included local excision, carbon dioxide
snow, bathing or the application of caustics. By far the
greatest number of ineffectively treated patients had
effective treatment later although in some, local recurrence
took place before a correct diagnosis was made and effective






Cases alive and well
at 10 years 1
at 5 years 1
at 3 years 1
Alive with disease
at 10 years 0
at 5 years 0
at s3 years 0
Dead of melanoma
at 10 years 2
at 5 years 2
at 3 years 2
Dead of other causes
0
Untraced 0




1 3 0 0
3 3 0 0
0 0 0 0
0 0 0 0
4 1 0 0
4 0 0 1
9 2 0 2














Biopsy before effective t
iJ£22£S—5 a.. #
43/71 (67.6) 31/59 (52.6)
42/63 (61.7) 27/55 (49.1)






comparatively small number* Total excision vas classed as
ineffective treatment so that the effect of cutting into the
tumour oould be compared. Table XI reveals that only biopsy
appears to have much of a deleterious effect upon the patient's
survival. Ineffective treatment, so long as effective
treatment follows, is not as fatal a step as many authors
believe (PACK, 19471 STLVEN, 19491 CADE, 1957). It is
however important to realise that all local excisions of
pigmented spots for histological examination are included in
this group and effective treatment in those followed fairly
quickly. Further since survival is dated from this excision -
since it was a form of treatment - they are rendered more
comparable to those whose first medical attendant made a
correct clinical diagnosis and instituted what is deemed to be
correct treatment. Other series probably date their survival
from the date of their referral to the centre by which time of
course gross recurrence has often taken place.
For those cases who had biopsy it can be seen from
Table XII that it makes little difference whether the biopsy
was taken at the time of operation and reported by frozen
seotion or a paraffin section is perused at leisure with a
second more radical operation up to 4 weeks later. Table XIII
reveals no significant difference between the survival rates of
Table Aj II
Stage9 Treatment and Survival.
Treatment policy Surgery Radiotherapy Surgery;recurrence}
_ . , radiotherapyDeterminate cases on|y
Stage I or A 18/26 (69.2*) 39/55 (70.9$) 0
Stage II or B 2/5 (40 0$) 8/16 (50.0%) 5/11 (45.5$)
Stage III or C 0 0/4 (0 0$) 15/29 (51.7$)
Three year survivors
All stages 20/31 (64.5%) 47/75 (62.2%) 20/40 (50.0%)
Stage I or A l/ll (63.6%) 29/49 (59.2$) 0
Stage II or B 1/4 (25.0$) 4/13(30.8$) :. (33.3$)
Stage III or C 0 0/4 (0.0%) 8/16 (50.0$)
D'ive year survivors
8/15 (53.2$) 33/66 (50.0$) :1/25 (44.0$)
Stage I or A 1/3 (33.3$) 20/37 (54.0$) 0
Stage II or B 0/1 (0.0$) 4/8 (50.0$) 1/4 (25.0$)
Stage III or C 0 0/2 (0.0$) 2/9 (22.2$)
Ten year survivors
**
All stages 1-4 (25.0$) 24/47 (51.0$) 3/13 (23.0%)
Table XIV
Snd ResultThe State of All Gases at the Completion of the Survey.
Determinate group.
Less than 3 years
3 to 5 years







































Dead of other disease Lost to follow up
Less than 3 years
3 to 5 years































interval they have been used in the survival rates.
Table XV
End Result and Size According to Treatment Policy and. Site.
A* First effective treatment surgery: no radiotherapy at any tine.
Sites Head and neck Arm Trunk Leg Foot Eye
Indeterminate cases . 3 1 2 1 1 0
Survivors; Stage I 24/29 6/7 5/13 12/15 1/3 0/1
Survivors; All Stages 26/^2 7/io 7/15 15/19 1/3 0/1
Sizes up to 2 cm. 25 9 7 13 2 0
over 2 cm. 4 2 4 1 1 0
Unknown 6 0 6 6 1 1
B. First effective treatment radiation.
Sites Head and neck Arm Trunk Leg Foot Genital iiye
Indeterminate cases 10 2 4 3 1 0 0
Survivors; Stage I 7/27 1/3 0/5 5/9 1/4 0/1 0/1
Survivors; All Stages 7/33 1/3 o/6 .7/1.3 1/5 0/1 0/1
Sizes up to 2 cm. 22 3 4 9 4 1 1
over 2 cm. 10 2 5 6 2 0 0
Unknown 11 0 1 1 0 0 0
C. Surgery - recurrence - radiation.
Sites Head and neck Arm Trunic Leg Foot We
Indeterminate cases 0 1 1 1 0 0
Survivors; Stage I 1/4 1/3 0/4 • 5/10 1/4 0/4
Survivors; All Stages 2/6 1/4 0/11 6/1.4 1/5 0/4
Sizes up to 2 cm. 3 2 4 8 3 1
over 2 cm. 2 0 2 2 0 0
Unknown 1 3 6 5 2 3
D. Palliative therapy only.
Head and
Sites neck Arm Hand Trunk Leg Foot Genit i :^ye Meninges ?
Indeterminate cases 2 0 0 3 0 1 0 0 0 0
Survivors; Stage I 2/6 0 1/1 0/5 3/6 0/1 0 0 1/1 0
Survivors; All Stages 2/11 0/2 1/1 2/13 4/11 0/3 0/1 1/2 1/1 0/i
Sizes up to 2 cm. 4 0 0 5 3 2 0 0 0 0
over 2 cm. 4 1 0 8 1 2 1 1 1 0
Unknown 5 1 1 3 7 0 0 1 0 4
16
radiation and surgery as the first effective treatment at 3
or 5 years. In spite of the wide percentage difference
between those at 10 years the numbers are too small to attach
any importance to them.
Bad Result. The state of all cases at the end of 1959
is shown in Table XIV. Although 283 melanomata are considered
they represent only 282 patients since one female had two
separate histologically proven primaries. The first, on the
face, was implanted in 1931. She remained well and was
discharged from follow up only to be referred back in 1958
well over 80 years old with a fresh subungual melanoma on the
foot which had given rise to inoperable nodes. She therefore
is recorded twice, onoe dying of other disease 28 years after
primary treatment and once among the no treatment given group.
Multiple primaries present simultaneously were noted in two
cases. They are shown under "primary unknown" in Table VIII.
Any case known to have died of melanoma after an
assessment year is shown as alive with disease in that year.
Table XV summarises site, stage, size and end result for
the three radical treatment groups. Pure surgery has a
spurious advantage in this table since most cases were
operated on after 1956. The survival figures are shown in Table
XIII.
a j. ■ xvi
Block Dleaectior«
Stage I cases (Prophylactic)
Alive and well Alive with melanoma Bead Untraced
Nodes negative 18 4 70
Treated before 1957 2 1 6 0
Nodes positive 5 1 1 1
Treated before 1957 1 1 0 0
Stage II case3 (Therapeutic)
Nodes negative 3 0 1 1
Treated before 1957 3 0 1 1
Nodes positive 3 3 14 2
Treated before 1957 0 2 13 2
Average survival of dead oases.
Stage I » 33 months
Stag© lis 26 months
Table XVIII
liaoiation Treatment of Hones.
Stage I cases (prophylactic)
'vi J.,' y
Xray therapy: 1 case. 6 era. primary on foot. Xray therapy to
to popliteal fossa find, groin, Well 3ir years later
but lost to follow up.
Kadon needle implant:
Primary on head and neck, size unknown. Implant to
neck. Well 16 years later.
1.0 cm. primary on face, hied without recurrence in
the treated area within 12 months. Ineffectual
treatment 3 months prior to implantation.
Stage II cases (therapeutic)
Xnay therapy: 5 cases.
2.0 cm, melanoma on upper limb. Axillary nodes
resolved. ho recurrence. Well 18 years later.
4.0 cm. primary on lower limb, recurrent 2 yea s
after inadequate treat lent, Xray therapy to primary
and nodes in moderate dosage. Well 19 years after
first attempt at treatment, 17 years after recurrence.
2.0 era. melanoma on leg. Xray therapy and implant
resulted in radionecrosis requiring skin graft
(excised specimen tumour free). Well 2-g years later.
2.0 cm. tumour on trunk. Combined excision and Xrays
to axilla. Keourred within 12 months. Died after
chemotherapy and further excision within 2 years.
2.0 cm. primary on leg. Xray therapy at very slow
dose rate to primary, and nodes. Heeurred at 3 months
and died at 6 months.
Implant: 9 cases.
4.0 cm. primary on head and neck. Kequired 2 implants
to clear persistent disease, hied of other causes
at 2§- years.
2.0 cm. melanoma on leg. hied of other causes 1 year
11 months later.
Two cases with 4»0 cm. primaries on the head and neck
died of disease but without recurrence in the treated
area, 1-^ and 3 years later.
3.0 cm. head and neck tumour, inadequately exoised
nodes implanted; died of disease 1 year 8 months later
Two on head and neck and two on leg and foot died
5 months to 3 years af'er a moderate response of the
nodes in three and complete clearing in one. All of
melanoma.
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Treatment of Lymph Drainage Areas, Little attempt was
made prior to 1956 to treat the lymph drainage fields if it
was not clinically involved. "Prophylactic" block dissection
of neck groins or axillae was seldom performed for melano-
carcinoma hut was more commonly used than radiation for the
radical treatment of enlarged nodes. The results of surgery
to the immediate drainage area are shown in Table XVI. The
numbers are obviously too small to draw conclusions but it
does appear that a negative pathological report on the
draining nodes is not necessarily a sign that all the disease
has been removed.
Therapeutic dissection was completely unprofitable in
that of the four who remained alive and well at 3 years, none
had tumour in the draining nodes. There was no obvious
prolongation of the life of those who died when the average
survival of the dead cases is compared with the whole series
(Table XXI). .
Table XVIII details the radiation treatment of nodes.
Par too few cases were irradiated "prophylactically" to draw
any sort of conclusion so that this form of treatment remains
untried. Of the Stage 11 cases only those treated with Xray
therapy show any reasonable survival and of course no proof
Table XIX
Speed of Recurrence and. Survival
Recurrent in Total Died within
that year
1st year 39 12
2nd year 27 5
3rd year 18 3
4th year 4 1
5th year 3 0
5 to 10 years _£
Total 24 21
Survived twice Survived four times








is available that the nodes were involved. Patients vith
enlarged nodes implanted first all died within 3 years
although two of the nine succumbed to intercurrent disease.
One case obtained only a partial remission and one recurred
locally.
Metastases and Recurrences. No tissue was immune from
haeoatogenous deposits except apparently cartilage but the
favoured sites were the subcutaneous tissues, brain, liver,
lung and bone, in that order. At post mortem deposits were
found in such uncommon sites as the spleen, skeletal muscle,
cardiac muscle and thyroid. It may be that the apparent
sparing of cartilage was not a real one since no routine
sections were taken and microscopic metastases may have been
present. The lack of gross tumour may have been related to
the relatively poor blood supply.
A tumour which recurs quickly or in which metastatic
deposits appeared shortly after treatment might be thought
to be more rapidly fatal than others of a similar nature,
but it can be seen that from Table XIX this is not necessarily
so since an appreciable number of patients lived for over
four times the period between treatment and the appearance of
recurrence. In most cases this was local recurrence or the
Table XX
Treatment of Metastases and Recurrence Other than Nodes
1. Surgery 6 alive and ell 2—3 years after excision of metastases.
One had Xray therapy to a supposd recurrent nodule.
6 alive with disease; 5 cases 1-3 years after treatment and
one 7 years after first reexcision culminating in f »re-
cuarter amputation. Two had Xray therapy in low dosage.
3 untraced immediately after surgery.
18 died of melanoma 1-5 years later.
2 died of melanoma 10 and 12 years after excision which had
to be repeated.
Xray therapy was used at some stage in 17 cases for further recurrence
2. Implant 1 alive and well 14 years later.
1 alive with disease at 3 years.
1 dead of other disease 26 years after implant but a remnant
was excised locally.
3 untraced 2, 3» and 4 years after retreatment.
15 died of melanoma 0-5 years.
2 died of melanoma over 10 years after treatment of recurrence.
3. Xray therapy
a) XHT - recurrence - implant
1 untraced after 1? months.
1 died of melanoma 3 years later.
b) XHT - recurrence - excision
1 alive and well 5 years after XHT and 1 year after excision.
c) XHT alone
2 alive and well 8 and 10 years after XHT to recurrent nodes.
5 alive with disease 1-3 years.
2 untraced at 3 months.
1 died of other causes but with disease present at 5 years.
20 died of melanoma 1-7 years after treatment.
Table XXII
Chemothe apy,
Responses 1. Cyclophosphamide. Complete remission for 12 months of cerebral
metastases, groin and axillary noues,
2. Nitrogen mustard. Shrinkage of an axillary mass but combined
with Xray therapy.
3. ditro en mustard. Shrinkage of primary tumour but also had Xray
therapy.
Failures
4* Thiotepa. Temporary relief of bone pain.
5# Tretapine. Objective partial remission on several occasions
with combined local injections and systemic courses of treatment.
18 cases showed no response to any compounds of the nitrogen mustard
group, Uarcolysin, Actinomycin D, "Tapazole", Sananqrcin and various
other cytotoxics on clinical trial for anti-tumour activity, either
alone or in combination.
Table XXI
Duration of Life of Dead Cases.
Stage I
No treatment 12 years (1 case)
Surgery alone 3 years 3 mo.
Radiation first 4 years 5 no.
Surgery - recurrence IB 3 years
-radiation IC 3 years 7 mo.
Palliative therapy IB 3 years 1 mo.
10 3 years 3 no.
Stage II
1 year 4 mo.
1 year 7 mo,
1 year 6 mo.
IIB 0 year 8 mo.
IIC lyear 10 mo.
IIB 1 year 6 mo.
IIC 0 year 11 no.
Stage III
0 year 2 mo
1 year 4 mo
1 year 4 mo
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enlargement of draining lymph nodes but it still indicates
that treatment seems to modify the course of the disease
assuming that the tumour's characteristic growth rate
remains constant and differences in host resistance at
different sites or at different times are discounted.
Unfortunately this assumption is not always valid with
malignant melanoma since this neoplasm is one of those
known to undergo spontaneous regression. This may explain
the long survival of the Stage I case who had no treatment
but lived for 12 years.
The Treatment of Metastases and Recurrence. The methods
used and their efficacy are set out in Table XX.
Survival of dead cases. Where survival rates are very
similar a comparison of the value of treatments might bo made
by examining the duration of life of the dead cases. This is
done in Table XXI. It will be seen that radiation has an
apparent 33*3$ advantage over surgery in this respect but
this may be fallacious in that more irradiated cases are
available for ten year assessment.
Palliation. Chemotherapy was used in 23 oases
(Table XXII). 18 showed no response to a variety of agents.
2 others had Xray therapy as well as cytotoxic drugs with
Table XXIV
Pregnancy, 3 years 5 years
S.fi. S.H.
Malignancy appeared in relation to a pregnancy 13 5/8 3/5
3 of these had subsequent pregnancies between
the apparent transformation and treatment without
appreciable effect upon the primary.
Pregnancy following treatment 4 3/3 3/3
1 untraced after 2 years.
.horapy.
1. Aged 30. Melanoma ap .eared dux im one pregnancy but subsequent
pt egnanoies had no effect on the primary or later, her metastases
Kadiatlon munopauoo with a temporary 1 ; rovercon't In p aeral
condition. Alive with disease 3 years after treatment at end of
series.
2. Aged 4m* degression of nodes and nodulos at time of natural
menopause but eventually died 11 years after Implant and $
years after appearance of ffletast.ases.
3* Aged ?•: . Ovarian irradiation given "prophylaotically". Lost
to follow up after A years but well it 1 st report.
1. Af ed 40* Oross recurrence after forequarter amputation. No
response to orchidno touy or hypophyssct ty. Various forms of
chemotherapy were equ-lly unsuccessful. There was no recurrence
in several areas treated by Xray therapy, hied 4 years after
first treatment.
2. /'ged 20. Pituitary irradiation had no effect on multiple
nodules, hied 2 years and 1 months after inef'ective treatment
to the primary.
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temporary response. Local Injections into a perineal mass
combined with a systemic oourse of "Tretamine" resulted in
partial objective remission on three separate occasions in
one patient, while another had subjective relief of pain
from bony metastases following a course of "Thiotepa". The
only worthwhile response was in a case with oerebral
metastases, groin and axillary nodes who survived a further
12 months following the injection of a large single dose
(40 mgms per kilo) of cyclophosphamide. Phenyl alanine
mustard was not available for trial prior to 1959*
hormonal therapy appeared to have some effect in
2 females although one of these may have been a spontaneous
regression. It appeared in relation to her natural menopause
and it is therefore classified as a hormonal effect. Two
males failed to improve with orchidectoay and hypophysectomy
or pituitary radiation. There was no obvious ohange in
pigmentation following removal of the pituitary (Table XXIII).
Pregnancy. Although the primary lesion appeared in
relation to a pregnancy in 14 oases, 3 of these had children
subsequently without deterioration. A further 4 cases became
pregnant after the treatment of their melanoma but without
detectable effect on the progress of their disease (Table XXIV),
Table XXV
Response to radiation.











Moderate dosage Low dosage
(3 - 6,000 rada) (0 - 3,000rads)
Comp. Incomp. None Comp. Incotnp. None
2 0 0 0 0 0
0 0 0 0 0 0
(2 - 4»000 rads) (0 - 2,000 rads)
18 12 6 4 6 9
0 0 0 0 0 0
Table XXVI
Survival of radionecrotic cases.
10 year survival rate
Available for assessment 18
determinate cases 17
Survivors 8
Survival rate 8/17 (47«1$)
5 year survival rate
Available for assessment 19
Determinate cases 18
Survivors 11
Surviv 1 rate ll/l8 (6l.l/$
2 lost to follow up between 10 and
15 years. 1 died of a second
primary melanoma, 28 years after the
first (histologically proven in both
cases).
3 year survival rate
Available for assessment 19 1 case alive with disease at 4 years
Determinate cases 19 9 months.
Survivors 13
Survival rate 13/19 (63.4'/)
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Response to Irradiation. Implantation of radioactive
needles was used on 61 occasions in which response could be
observed. Postoperative and "prophylactic" irradiation of
the node area is ignored unless recurrence took place within
the treated area in which event the case is counted as no
response. A breakdown of the total experience is shown in
Table XXV with the incidence of radionecrosis* 106 courses
of Xray therapy were assessable. Although the total dosage
of some of these was high, several of the failures were treated
over prolonged periods on a "growth restraint" basis aimed at
damaging cells in mitosis. Complete response (Comp.) is
clinical clearing of palpable disease in the treated area
without recurrence within that area or adjacent to it.
Incomplete response (incom,) includes those which recurred
after disappearance had been achieved and those in whom an
observable and recorded diminution of the tumour mass ?/as
obtained but residual induration or tumour persisted.
Persistence of pigmentation without palpable disease did not
exolude a case from the complete response group.
Radio-necrosis was an inconvenient and sometimes
distressing accompaniment of the high dose used on oooasion.
It was more common after implant than Xrays. The survival
rates for these 19 cases are somewhat better than those for
the radiation group as a whole. (Table XXVI).
Table XXVII





Recurrence in the Treated Area. After radiation 23
oases recurred in the treatment field or at its edge after
clearing. If the incomplete and no responses are included
74 lesions showed an unsatisfactory local result from
radiation out of a total of 167 courses. This can be
compared with 135 cases treated by surgery of whom 67 have
reourred in the dissected area in a shorter overall
observation period. However there was no way of gauging the
adequacy of the surgery in some of these as the excision was
performed elsewhere and information was incomplete. An
additional 10 cases showed reappearance of disease after both




It is not proposed to enter the arena on the contentious
issue of the embryological origin of the cell of malignant
melanoma* Convincing demonatrations can he obtained from the
varied histology of the tumour to support almost any contention*
The fraying of the basal layers of the epidermis into the
naevus formation and the implication of the epithelium in the
advancing edge of the neoplasm pictured in DAWSOU's monograph
(1925) and ALLEN and SPITZ*s work (1923) point to an epithelial
origin, but the stained, teased specimens in that of PETERSEN,
BODEHEAM and LLOYD (1962) and the silver impregnated seotions
shown by MASSON (1951) are sufficiently reminiscent of nerve
cells to lend support to MASSON * s theory of two components in
at least some naevi. This may explain some of the varied
clinical behaviour of the tumour*
Pathology.
The pathologists have however drawn attention to the
very different prognosis of the grades of melanomata
described by ALLEN and SPITZ (1953) as Junctional naevus,
active junctional naevus, superficial melanocarcinoma, and
invasive melanocarcinoma depending upon the depth of invasion
24.
of the dermis. According to these authors and Mc-HOKTEK and
WOOLNEB (1954) juvenile melanoma is a relatively benign variant
which is distinguishable histologically and ocdurs in adults
although less commonly than in children*
Any lesion described as a malignant melanoma in a
prepubertal subject must be suspected to belong to that
category particularly if the patient survives* ALLEN and SPITZ
even describe tbe occurrence of apparent lymph node metastasis
in juvenile melanoma but claim the cells, which are shown in
the peripheral sinus of a node, are not invading the node but
rather are sterile emboli* Three patients in this series were
15 years or under. One girl of 15 died of disseminated
melanoma 8 months after wide excision of a 3.0 cm. primary on
her trunk. The second case, a 3^ year old boy died of a
melanoma arising in the iris 4 months after enucleation. The
last was also a 3& year old boy at the time of diagnosis. A
3.0 cm. amelanotio melanocarcinoma on the leg was excised in
March 1947 after being treated for l£ years as a keloid scar.
After wide excision and groin dissection nodes recurred in the
groin and were implanted. He remains well 15 years later
without further recurrence. The section has been reviewed on
many occasions by several pathologists who all agree that it
conforms to the criteria of malignant melanoma and is not a
juvenile melanoma.
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Some series (LUND and IHNEN, 19551 JAMES, 19581
PANAYOTIS et al, 1962) fail to state what proportion of
superficial melanocarcinomas if any, was found. Every effort
has been made to eliminate all but the true invasive
melanomata and hence they are comparable with Stage ill
melanoma (PETERSEN et al, 1962). These had a 5 year survival
rate of 50# which is the same as those radically treated in
the present series and 5# more than the overall survival rate.
Aetiology.
i) Pre existing naevi. It was not possible on the
histories available to make any reliable estimate of pre
existing lesions but from clinical experience, the impression
is gained that most melanomata arise in association with
pre existing naevi. This is confirmed by a survey of cutaneous
melanomata conducted by the Anti Cancer Council of Victoria
1962. As the distribution of lentiglnes is almost universal
among the white races, but melanomata are by no means common,
some other factor or factors must be operative. Further the
site distribution quoted by PACK, (1959) indicates a variation
in the malignant propensity of moles according to the region
involved.
ii) Sunlight. Evidence that one factor in the
transformation to malignancy may be sunlight is given by
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LANCASTER (195^ and 1957) wbo related the incidence of
malignant melanoma to geographical latitude and the average
daily hours of sunshine. The highest relative incidence
recorded was in Queensland, Australia with a yearly death
rate per million population of 23* This compares with an
overall inoidence in the U.S.A. of 10 per million, England
and Wales 6, Sootland 4 per million and Eire 3 per million.
The distribution of primaries as regards site tends to
bear this out. All series in which site inoidence is quoted
show similar trends. The head and neck and the lower limbs
are the most commonly affected regions of the body surface.
The lower limbs in CADE's 1957 aeries stands out as the most
often affected region but most other authors (TOMPKINS, 1953*
LUND and IHNEN, 1955* JAMES, 19581 VOGLEE et al, 1958*
PANAYOTIS et al, 1962* SCHARNAGEL, I9331 SYLVEN, 1949*
NITTER, 1956» JORGSHOLM and ENGDAHL, I955) have quoted an
almost equal inoidence or a preponderance of head and neck
cases. Only in the U.S.S.R. is this pattern disturbed. On
the basis of the low proportion of head and neck lesions
ultraviolet light has been specifically exonerated as an
aetiological factor (MEL'NIKOV and FEDOREYEV, I962).
Where the sex is given there are more females them males
in lower limb primaries (JORGSHOLM and ENGDAHL, 1955) but the
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difference quoted is far less than that found in the present
series hut no division into leg and foot cases is given. The
difference is significant at the 0.1% level of probability.
Trunk lesions are more common in males but this is not a
statistically proven trend. Head and neck cases are
approximately equally divided between the sexes but scalp
lesions are reported to be more common in males (FOWLER, 1962).
Similarly while the toted lower limb cases contain twice as
many females as males the preponderance is mainly due to
lesions on the lower leg since buttock and thigh and foot and
ankle lesions are almost equally distributed (FOWLER, 1962).
This dissection of cases would Indicate some modifying factor
and it would appear reasonable to postulate clothing
differences as an explanation. The loss of head hair in
males would be a more acceptable theory than the relative
frequency of hat wearing. In addition the proportion of
melanomata arising on the trunk is somewhat higher than in the
other series quoted corresponding to the national habit of
males stripping to the waist both for work and recreation.
National habitus may also explain the relative paucity of
leg lesions in the series from Scandinavia.
iii) Trauma. Although only 8.1J6 of the melanomata in
this series arose in the foot while other series quote
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proportions double this figure (SCHARNAGEL, 1933* JORGSHOLM
and ENGDAHL, 1955* PETERSEN et al 1962) this may only mean
the swamping of this series by the more numerous lesions
elsewhere. It may be that if it was possible to relate the
number of foot lesions to the population at risk the
proportion would be constant for Caucasians. The fact remains
that for the area at risk the sole of the foot is a favoured
site of origin. PETERSEN et al (1962) have attributed this
to the role of trauma and have drawn attention to the
increased proportion of melanomata arising below the ankles
in Negro populations. There is however an alternative
explanation for this latter finding in the relative sparseness
of lesions elsewhere on the Negro body. However LEVENE (1958)
in a survey of the actual site on the foot found 20 on the
dorsum and 32 on the sole. Mapping of the lesions reveals that
the melanomata were grouped quite distinctly around the non
weight bearing instep so that the theory of pressure being
related either to the inoldence or the poor prognosis of
melanomata on the feet requires re-examination.
Other trauma in the form of injury or "chronio irritation"
is frequently cited both by patients and investigators as a
cause of malignancy appearing in a hitherto innocent junctional
or compound naevus. The data available on the records reviewed
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was deficient in many cases on this point so that no evidence
is presented either way. Deliberate trauma in the form of
incisional biopsy is considered later.
iv) Pregnancy. GEORGE, FORTNEK and PACK (i960)
reviewed 77 cases of melanoma in which the onset coinoided
with pregnancy. The 5 and 10 year survival rates did not
differ appreciably from those in whom pregnancy developed
subsequently nor from a group of 330 controls. This reversed
a previous opinion of one of the authors (PACK, I948) that a
melanoma developing during pregnancy inevitably led to an
early death. Ho other controlled series could be found in
the literature but STEVEN (1949) found pregnancy "affected the
course of the disease" in 6 out of 341 oases only one of whom
became pregnant subsequent to the development of her
malignancy. McNEER (1958) claims that pregnancy does affect
the growth without substantiating the statement. LAHE, LATTES
and MALM (1959) formed the reverse opinion in a series of 117
cases claiming that only the depth of pigmentation was
affected by the hormonal changes.
In the present review, although 13 cases developed their
malignant moles in relation to a pregnancy 3 of these repeated
the supposed precipitating factor without further noticeable
change. The only effect upon the survival rate appears to
30.
have been an improvement. Pour others had subsequent
pregnancies following treatment of their disease. No latent
metastases appeared as all remained well while under
observation. Two were lost to follow up 2 and 11 years
after treatment but the others remain alive and well 5 and
9 years later. The last patient had several pregnancies
terminated because of fear of the effect upon her melanoma.
This would appear to indicate that while individual
oases may appear to light up during a pregnancy, the
coincidence of the exacerbation of the neoplasm and parturition
is fortuitous. Had the patients not become pregnant the
disease might well have run the same course. 64 women of the
series were in the child bearing period (16 - 45 years). If
1947 is taken as a typical year in the period under review 7
births or stillbirths would have been expected in a random
sample of this number. This is not significantly different
since the numbers are so small but does tend to support the
association of pregnancy with the development of malignant
melanoma although the other findings refute the opinion that
the prognosis is worsened.
Clinical Presentation.
It cannot be emphasised too often that any pigmented
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lesion, with a history of rapid growth, particularly arising
in a mole, must not he treated lightly. With experience as
PETERSEN et al (1962) say , it is possible to diagnose
malignant melanoma on clinical grounds alone hut even the
most experienced surgeon, dermatologist or radiotherapist may
make mistakes (HICKS et al, 1955)*
Many of the histories and cllnioal descriptions reviewed
in this series were inadequate in their description of the
primary lesion and unfortunately most of the clinical photographs
in the period of greatest Interest were destroyed so that no
attempt has heen made to study the frequency of modes
presentation. However attention is drawn to the work of
TOMPKINS (1953) and PETERSEN et al'(l962) pointing out the
grave prognostic significance of ulceration.
Where doubt exists in the mind of the experienced
clinician it would appear that the prognosis is better since the
lesion is more often of the superficial or juvenile variety if
it is indeed a malignant melanoma. Other conditions mimicking
malignant melanoma on clinical inspection alone include acanthotic
naevi, junctional or compound naevi with superadded infection,
pigmented basal cell carcinomata, sclerosing or ulcerated
haemangiomata and pigmented papillomata. The rare unpigmented
variety can be mistaken for virtually any ulcerated or
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papular condition if the preceding naevus has heen destroyed
by the neoplasm. The prepubertal boy who survived was
originally diagnosed as a keloid. The only clue to the
correct diagnosis lies in the ring of pigment which is
frequently present or in the pigmented lesion from which the
tumour sprang.
HICKS, RANK and WAKEFIELD (1955) produced a review of
clinical diagnosis in their series of 42 patients. Most
were oorrectly diagnosed but the proportion of benign or
relatively benign conditions mis taken for malignant melanoma
1b quite high. This would fall with more experience. In a
paper assessing the accuracy of frozen section (MILTON and
JELIKOVSKI, 1962) the clinical diagnosis was correct in the
great majority of cases.
The formation of a red ring around a pigmented lesion is
unfortunately more apt to be taken for supervening inflammation.
The lesion is therefore more likely to be misdiagnosed in the
presence of a "reactive halo" than without it. Its significance
as far as the patient is concerned is obscure. No figures can be
adduced from the series to prove the effect upon survival of the
red zone surrounding the primary tumour or its metastases.
Clinical experience of patients presenting subsequent to the
Fig. 2. The reactive halo. The lesion in the lower right comer
is a subcutaneous metastasis which has had no radiotherapy. It lies
below an area of radiation scarring from the posterior field applied
to the right axilla. Over the left trapezius is a further circular
radiation scar where a similar subcutaneous deposit with a reactive
halo lay 18 months previously.
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series tends to confirm that the reaction is rarely inflammatory
even in ulcerated cases. It can appear around subcutaneous
nodules (figure 2) and in one case involved the whole shoulder
where axillary nodes had been invaded. It does not in my
experience disappear rapidly with irradiation but can be
abolished by the administration of corticosteroids* This
*
latter finding was dictated by desperation in the patient whose
shoulder was involved by an acutely painful red reaction. Only
potent analgesics gave relief and prednisolone was prescribed
as a trial. A dosage of 40 mgm per day gave prompt relief of
symptoms.
Very little is said in the literature about the phenomenon.
A "halo" is mentioned as a clinical feature but appears to mean a
variety of things ranging from a zone of pallor around the
tumour to the pigment halo around a compound naevus. In the
present context the reactive zone described above is intended.
No comment on its genesis, treatment or significance has been
found. Too few cases are available for comparison or statistical
analysis but in the few patients in whom it has been recorded
the lesions have been only moderately radiosensitive. It appears
sporadically around some subcutaneous metastases and not others.
It has been noted in the patient mentioned above that those
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lesions which presented a zone of hyperaemia have persisted
sometimes unchanged hut usually diminished in size after
radiotherapy and chemotherapy to intensive levels while others
without it have disappeared completely and have not recurred
over 12 months*
No patient has died with the zone present so that in the
absence of biopsy it is not possible to present any pathological
findings on the cellular accumulation. It has not been noted in
patients with what might be termed intradermal metastases so
that it may represent a reaction to pigment in the subcutaneous
tissues assuming that this pigment lies outside the normal
macrophages which under more usual circumstances bear excess
melanin away. Similarly it is found around lesions which are
markedly pigmented. Some of them are more deeply placed so that
the colour is largely hidden but pressure over the nodule
thinning the overlying skin and blanching the reddened area
will reveal the bluish tint of the underlying pigment. The
inferenoe is made that some metastases and some primaries allow
pigment to escape from the tumour cells. This might well occur
if avascular necrosis takes place in the tumour mass thus
providing an explanation for both the halo and the radio - and
chemo resistance. Since melanin is normally present in the
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avascular epidermis and immediately it is released into the
dermis it is taken up hy the "chromatophores^ no reaction
would presumably take place.
Following irradiation or chemotherapy the halo slowly
disappears taking a month approximately to vanish. The process
may be masked by the radiation reaction but its evolution is
visible following the administration of an effective chemo-
therapeutio agent. This would be compatible with the dispersal
of the melanin crystals by the normal mechanisms and assumes
that some effect of the treatment has been achieved since no
more melanin is released immediately. If this is the case the
disappearance of a halo can be used an an indicator of the
effect of treatment even when little or no diminution of the
tumour size is apparent. Equally it is an indicator of the
relative radioresistance of the lesion under conventional
conditions since the oxygen tension in such a nodule is almost
certainly reduced. It cannot be taken to indicate resistance
of the patient to the neoplastic process since it is more likely
to be due to the presence of melanin or its breakdown products
in an abnormal situation.
Prophylaxis.
Much has already been written by PACK (1959)» CADE (1957)
and others (BLOCK et al, 1961) on the relative incidence of
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naevi and the supervention therein of malignant melanoma. The
prevalence of lentigines estimated variously at 1 to 20 per
adult Caucasian makes their routine removal impossible in all
cases. However the transformation rate of these moles varies
from region to region of the body so that even with an incidence
of melanoma of only 6 to 23 per million population it becomes a
worthwhile procedure to remove routinely all junctional naevi
on the soles of the feet, the palms of the hands, the paronychial
tissues and the mucous membranes* These areas have far higher
malignancy rates per preceding naevus than any others in spite of
the preponderance overall of the head and neck, trunk and lower
limb primaries. In areas where chronic irritation is a factor
such as the belt, shoulder strap, corset bone, and suspender
regions, removal is also felt to be worthwhile, not solely
beoause of the increased risk of trauma, which is as yet an
open question, but the effect of the irritation in inflaming the
naevus may mask malignant transformation or alternatively
malignant transformation may be misdiagnosed as chronic irritation.
The effect of sunlight on the incidence of melanomata in
particular and skin malignancy in general is one which has
received too little publicity. In spite of the high incidence in
Australia no warning is given to the young of the dangers of
excessive sun exposure. The red haired, blue eyed adolescent
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is unfortunately just the type to txy hardest to produoe a
sun tan on a skin which more oommonly than others gives rise
to malignant melanoma (LANCASTER, 1957).
Biopsy.
Incisional biopsy is oondemned in all early cases in
almost every paper written on the treatment of this neoplasm.
The present review hears out the wisdom of this advice and
examines the effect of the time of biopsy in relation to
subsequent treatment. Attention is particularly drawn to the
finding that the proportion of alive to dead cases, although
the numbers are very small, is the same whether the biopsy is
performed at the time of operation (i.e. no delay between
biopsy and effective treatment) or an interval elapses between
the procedures. A frozen section to determine the extent of
treatment is therefore just as injurious as a more accurate
paraffin embedded one if the tissue is taken from the tumour
while it remains on the patient's skin. A recent article
reoommends the procedure in clinically suspicious lesions (MILTON
and JELIHOVSKT, 1962) but fails to emphasize that the lesion
must be excised in toto and not cut into. Moreover a close
analysis of the results in which clinical, frozen section and
paraffin section diagnoses were compared reveals that in only
one case was the surgeon about to perform less than what is
accepted as adequate excision for a malignant melanoma which
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he had diagnosed as a squamous celled oarcinoma. The frozen
section in this case was inconclusive between the two diagnoses.
In two cases the frozen section would have led to under-treatment
when the clinical diagnosis was in fact correct. In five, the
patient was saved a more extensive operation than was planned
but in one the surgeon was doubtful (3 basal cell oarcinomata,
one pyogenic granuloma, one seborrhoeic wart). Only the last
two cases would have lost much and it is probable that with
experience a more accurate clinical diagnosis would have been
made. It would therefore appear that the technique provides




The modalities listed under ineffective treatment include
local excision, electrocautery, ablation by caustics of various
kinds and bathing. Only the latter leaves the lesion in situ.
The results of this group of cases in whom effective treatment
was preceded by "tinkering" (CASE, 1957) are not significantly
inferior to those in whom effective treatment was initiated
Immediately if survival is dated from the time of the first
attempt at treatment. It would appear that much of the
condemnation is due to the fact that the patient is not
referred until recurrence has taken place which may be merely
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a stage further on in the course of the disease. Indeed one
is entitled to wonder how many melanomas are "cured" by
local excision of a mole at the first sign of enlargement.
PAMYOTIS et al (1962) refer to a patient who refused wider
excision and block dissection of a locally excised melanoma
which showed clear evidence of malignant cells in the
lymphatics but survived without recurrence for 25 years#
This surprising result must be contrasted with the
apparent effect of biopsy. In doubtful cases it would appear
to be acceptable to excise the lesion with minimal margins and
submit the entire tissue to the pathologist for decision on a
carefully prepared paraffin section. So long as adequate
treatment follows, the results should not be inferior to those
whose tumours received adequate treatment ab initio. Indeed
since the clinically obvious are usually ulcerated malignant
melanoraata while the doubtful are often equally dubious under
the microscope the results in this group may even be better
including as they will the superficial melanocarcinoraata, the
juvenile variety and the relatively more benign tumours
mentioned previously. The important point is that anything
excised from a patient should be referred for histological
examination no matter what the clinician thinks it is.
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Effective Treatment of the Primary Legion.
The original purpose of this study was to ascertain the
proportion of lesions which could he expected to respond
locally to radiation hut the results of this prohahly unique
series were so surprising that a more complete examination was
made. The several categories into which the cases are divided
are not strictly comparable although age, sex and site dis¬
tributions appear acceptably uniform between the radically
treated groups. However comparisons will inevitably be made
between surgery and radiation as to the results. These are very
similar for 3 and 5 year survival rates. So similar in fact
that the question must be raised of whether these figures
actually measure a beneficial effect of treatment or merely
reflect the growth pattern of the melanomata. The assertion
has been made for carcinoma of the breast that treatment merely
marks an incident in the course of the disease. This could
well be said of malignant melanoma.
Such an argument cannot easily be refuted on these two
groups alone. Indeed it is somewhat supported by the single
traced Stage I case who refused treatment after diagnosis and
died 12 years later with multiple metastases but no further
medical attention.
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It would appear to be more profitable to compare stage II
cases since these are the ones at a clinically definable point
in their progress. The primary lesion has declared itself by
producing clinically enlarged mobile operable nodes* Bsfore this
the primary may only be in an inactive stage, or at a developing
phase although every effort has been made to exclude this kind of
case in this series. After this point treatment Is seldom
curative and often impractical. No Stage II case, who received
no treatment and whose fate is known, lived for more than 3 years.
Of those who received radical treatment 2 of 5 surgical cases and
8 of 16 radiation cases remained alive at the 3 year point. One
of 4 and 4 of 13 respectively survived 5 years. At ten years
there were still 4 cases alive in the latter group out of 8
available for assessment. It would appear therefore that
treatment does exert some Influence on the disease and this may
be confirmed by a consideration of the span of life measured in
terms of the time between first treatment and the appearance of
further disease (Table XIX).
On the crude figures presented under survival rates it is
impossible to say that one form of treatment is preferable to
another although radiation appears to produce more long term
survivors. The surgical group however were started more recently
and may yet prove equal or superior to radiation. The apparent
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advantage of radiation can be attributed to the fact that
latent metastases or long delayed recurrences appear less
frequently or later in the radiation group. More will be said
about this later.
The group denoted as surgery without radiotherapy have
few long term cases for assessment. The reason for this lies
in the policy in vogue during the 1930'a and 1940*s. Obvious
malignant melanomata were implanted. Doubtful oases only were
referred for surgery. Since these will include the non
ulcerated cases there will be a bias in favour of surgery in
these cases. Further, since the recurrent cases treated by
radiotherapy are grouped separately, the pure surgical cases
are slightly more selected. A combination of the groups
treated primarily by surgery leads to a 3 year survival rate
of 40 out of 71 oases for surgery (56.3$) to compare with 47
out of 77 for radiation (61.0$). At 5 years 19 of 40 surgical
cases (47*5$) survived while 33 irradiated cases out of 66
survived (50.0$). The ten year figures for surgery and
radiation are respectively 4 of 17 cases and 24 of 47 (51»1$)»
In spite of this apparent doubling in the last figures the
surgical group is too small to allow statistically significant
comparison. The remainder are obviously very alike. PANAYOTIS
et al (1962) report a total of 30 survivors at 10 years out of
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116 cases treated (26$), A comparison of these with the present
2 , ,
results gives a x figure of 6.6 which indicates a statistically
significant difference exists at the 1# level of probability.
The figure of 50^6 5 year survival rate for radiation cases
corresponds well with HELLHIEOEL (1952) series comparing surgery
with irradiation. HULLEB-MIHY (1955) compiled the radiation
results from 14 German centres. Of a total of 71 oases
available for 3 year survival studies 67 were still alive, 3
having died of metastases and one of intercurrent disease. It
is however impossible from this work to gauge the selection or
staging of cases and histological evidence is specifically
excluded since the author found this unreliable. This figure of
9A$ 3 year survivals must therefore be treated with caution.
However it is unlikely that all but the 3 who died of metastases
were benign. Chaoul radiation was employed but no details of
technique or dosage are supplied* No later article has appeared
giving later survival figures.
Russian experience was quoted at a scientific conference
on vascular and pigmented tumours in February 1961 (MEL'NIKOV
and FED0REYE7). Their methods varied in detail from centre to
centre but consisted mainly of pre-operative short focus
Xirradiation directed to the primary followed by excision of any
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remnants. In 53 Stage I cases KHMELEVSKATA of Kiev reported
disappearance of all tumour in 29» 17 of whom survived 5
years, 12 of them 5 year cures. 24 cases showed some remnant
of pigment or tumour which was excised by electrocautery. Of
these 18 survived 5 years, 15 of them without recurrence.
These cases received 12,000 to 30,000 roentgens but no mention
is made of prophylactic treatment of nodes. In Stage II eases,
which includes ulcerated tumours and those with mobile nodes,
1 case of 10 who received Xray therapy alone survived 5 years
and 4 of 21 where surgery followed radiation but only 2 of these
were without recurrence. The conference concluded that pre¬
operative radiation was the treatment of choice.
This range, from PACK's condemnation cf radiation to
MULLER-MINT's complete faith in its ability to produce the best
results, is most confusing. The present series confirms
DICKSOIf's (1958) belief that radiation has a part to play in the
treatment of malignant melanoma but has not conclusively
established what that part should be. At a later stage in the
argument specific suggestions will be made.
Size, Sex. Stage and Site.
Although the size of the primary tumour correlates well
with the stage at which the patient presents, there appears to
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be less effect upon survival than is apparent with other
tumours notably breast carcinoma (McWHIRTER, 1957) particularly
if equivalent stages are compared. The dimensions of the
melanoma and hence its tissue pressures appear to be related
therefore more to lymphatic metastases than blood borne since
it is the latter which bring about death. LUHC and IHHEN (1955)
and PANAYOTIS, CHARALAMBIDIS and PATERSON (1962) did find a
difference in 5 year survival between lesions below 2.0 cm. and
above, viz. 46.1$ and 27.5$. The relevant figures in the present
series are 43* and 43.2jf. It will be seen that the proportion
of Stage I cases in the total falls steadily from 23/30 for
primaries up to 1.0 cm. to 7/15 for primaries over 4.0 cm. Prom
this proportion it could be inferred that most of the oases
whose tumour dimensions were unknown were 2.0 cm. or less. Their
survival rate matches this inference.
From Table X it can also be seen that males present at a
later stage and with larger tumours than females. Combining
Tables VIII and XV reveals that much of this anomaly is due to
the preponderance of trunk lesions in males. Such a lesion,
particularly on the back will escape notice for a considerable
time while one on the face is obvious at its first appearance.
Furthermore females naturally pay more attention to their skin.
Hales tend to postpone medical attention, minimise or even
ignore blemishes or alternatively try home remedies such as
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"blue atone", caustics or even red hot pokers before reporting
to their medical attendant. PETERSEN et al (1962) note that
32.3# of lesions on the trunk had already spread elsewhere by
the time the patient presented.
The site distribution in this series differs but little
from most others. Omitting primaries in the eye, the meninges
and the mucous membranes to confine the series to the cutaneous
melanomata alters the site distribution figures by only 1 to 2$
and improves the survival rates by a small margin. Pew series
break down the results of their cases according to the site
involved and no-one has broken the site results into sexes.
This dissection reveals that no significant difference exists
between the sexes at any site although trends can be seen
reflecting the overall slightly better outlook for females.
Prognosis according to site varies from series to series
but in general head and neck and upper limb lesions carry a
more favourable outlook (SYLVEN, 1949I JORGSHOLM and ENGDAHL,
1955; LUND and IHNEN, 1955, HITTER, I9561 VOOLER et al, 1958;
DICKSON, 1958| PETERSEN et al, 1962; PANAYOTIS et al, 1962).
However series differ on the outlook of primaries on the trunk
and lower limb. Some find the leg the most favoured site
47.
(eg. PETERSEN et al, 1962) some the worst (LUND and IHNEN, 1955).
Careful inspection of the 3» 9 end 10 year survival rates
in Tahle IX reveals first the extremely good prognosis for
patients with primaries on the leg and the poor outlook for those
on the trunk. The lower limb results must be contrasted with
those on the foot since the routes of spread should be exactly
the same. If anything the greater distance between the primary
and the nodes should;theoretically, be in the surgeon's favour.
The intermittent pressure of walking has been put forward as
the likely explanation but LEVENE (1958) has shown that the
majority of lesions are on the non weight bearing portions of
the foot and sole.
Secondly the difference in prognosis becomes more marked
the longer the oases are observed. This effect Is more
noticeable in the foot and head and neck lesions than in trunk
and lower limbs. The attrition between the 3rd, 5th and 10th
years is extreme in the aelanomata appearing on the foot
compared to those on the leg. This may reflect a difference in
the rate of progress of the disease at the various sites.
Primaries on the trunk appear to cause early death. Those on
the leg take much longer or are relatively more benign. One
oase exemplifying this was that of a male (not inoluded in the
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series as he presented after it ended) whose primaiy on the
calf was excised in 1941* Grossly involved nodes were later
incompletely removed from the groin and an incomplete course
of radiation was given. Twenty-one years later he reported
with tiny black epidermal recurrences adjacent to the graft
on his oalf. The groin remains clinically clear.
For mucous membrane melanomata the outlook is not so
good. Two primaries arose on the female genitalia both
proving fatal within 2 years of treatment. One male with a
primary in the nasal cavity which proved to be very radio¬
sensitive finally succumbed at the age of 97» 17 years after
his first treatment.
Age.
Although the excellent outlook of apparent malignant
melanomata in childhood has been known for many years the
literature does not contain many references to a difference in
the survival rates of those occurring below the age of 36 and
those after. LUBD and IHNEN (1955) speak of a better survival
rate in the younger patient while BLOCK and HARTWELL (1961)
publish a similar finding but no other article makes much of a
point of this. The differences (Table 711) border on
significance at 3 and 10 years and are significant at the 1.0#
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level for 5 year survival rates. This effect is not purely
one of the older age group containing a higher proportion of
advanced cases as perusal of Table VI will show that the trend
is clear in Stage I and Stage II cases taken separately.
The Treatment of Nodes.
i) "Prophylactic." BLOCK and HARTWELL (1961) point out
quite correctly that the so called "prophylactic" block
dissection is in fact "therapeutic" since no element of
prevention of the disease is present. The intention of the
operation is to remove disease already present but not clinically
detectable. However usage over the years has established the
meaning of the word and it will be retained here to mean the
dissection or treatment of nodes in a Stage I case.
It was clearly evident in the closing years of the last
century that excision of a melanoma was not enough to eradicate
the disease in the majority of cases. When HANDLEY's work
(1907) on the lymphatios confirmed EVE's suggestion (1903)
that spread from the primary might be encompassed by removing
the draining lymph nodes, surgical treatment appeared to hold
out new hope.
PACK (1959) in a review of the results of surgery over the
years found an improvement from Adair's review of 267 cases in
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1936 with a 12.0# 5 year survival through his own 1952 results
(21.5# overall) to the 1959 figure of 39«1#. This improvement
he attributes to earlier and more radioal surgery, earlier
diagnosis and the abandonment of radiation. The more radical
surgery presumably includes more radical removal of the draining
nodes. In 1952 he reported that 40.5# of 37 cases whose nodes
were tumour free, and 14.1# of those with pathological
involvement of the nodes (199 cases) survived 5 years. Of 204
oases who had wide local excision only 37.3# were 5 year
survivors which is not significantly different from the 37 cases
who had block dissection but had no pathologically confirmed
nodal involvement. Similarly LANE, LATTES and MAUI (1959)
reported that 67# of 24 cases survived with only wide local
excision. 14 cases were tumour free on block dissection and
71# survived. 49 cases showed nodal involvement pathologically
and 20# survived.
LUBD and IHNESf (1955) examined the question of the value
of "prophylactic" block dissection and claim suggestive
evidence that it does increase the survival rate but on the
small numbers presented in their paper no firm conclusion is
possible. BLOCK and HARTWELL (1961) go further in a detailed
analysis of 88 adequately treated cases in a total material of
217. They claim a 50# 5 year survival if the nodes are clear
and 25# if they are positive. They assert that it is possible
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in 90% of oases to assess the clinioal significance of nodes
accurately and therefore advocate an observational policy in
all hut head and neck cases which can he shown to derive some
benefit from the routine removal of the lymph drainage field.
They rightly point out that most surgical series are deficient
in the vital information of whether clinical nodal enlargement
was present. There is no indication in the survival figures of
those whose nodes are histologically positive of how many oases
were clinically Stage I cases and therefore no estimate can he
made of the proportion of cases which contain latent lymph node
metastases.
The figures from this review are too small to olarlfy the
question. Eleven Stage I cases were dissected "prophylactica!^"
before 1957 (Table XVI). Six had died by the end of 1959 all
having had apparently negative nodes. Two of the survivors had
reourred and only 3 remained well. In one of these the
pathologist had reported tumour present.
It may be argued that in many of the oases where nodes
are reported tumour free there are in fact some cells present
but they have not shown up in the sections cut. Serial seotions
of all the nodes in a olarified specimen have not been performed.
However such an argument also strengthens the result of those
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whose lymphatic harriers were not disturbed since their prognosis
is not far different from those where nodes were reported to be
free of tumour. There would have been an equal chance of these
patients having minor deposits in their nodes, assuming an equal
grade of malignancy. Dissection however is more likely to be
omitted in non ulcerated small tumours of low grade malignancy so
that this assertion may not be completely valid.
The nodes of only 3 cases were treated "prophylactically"
by radiation. The results detailed in Table XVIII are quite
inconclusive. Only STLVEN (1949) and HITTER (1956) report
prophylactic irradiation of the lymph drainage area although
DICKSON (1958) advocates post dissection irradiation in all
oases whether the pathologist can see involvement or not.
Siylven reports no survivors of 4 treated with radiation alone
(1,400 - 2,000r), 2 of 26 with surgery alone, 1 of 12 with
pre-operative radiation, 3 of 10 with post-operative radiation.
Nitter is much more encouraging, contrasting 11 survivors at 5
years of 24 treated with prophylactic radiation and 18 of 54
who had no irradiation (determinate cases 11/22 and 18/30
respectively). Again the dosage used is well below tolerance
levels. The Russian work quoted previously is not clear on the
results obtained by prophylactic irradiation but the dosages
used for patients with clinically involved nodes are at the
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other extreme (6,000 to 7»000 r). Prophylactic irradiation of
the lymph drainage areas at tolerable but effective dose levels
remains therefore a substantially untried method of treatment.
ii) Therapeutic, As mentioned previously moat surgical
series divide their cases according to histology and not on a
clinical basis. While a small proportion of patients with
clinically involved nodes in which the pathologist fails to
find tumour, will be included in the histologically negative
group a larger number will be transferred the other way i.e.
clinioally negative but histologically positive. This
effectively will improve the results of both stages (McWHIRTER,
1957) without casting any light on the results of treatment by
clinical stages.
In this study the clinical appearance of the nodes has
been recorded in every case so that a clinical assessment is
possible. More Stage II cases had a block dissection in the
earlier years than Stage I. Hineteen cases are available for
3 year results. Fourteen had died by this time and 2 had
recurred but were still alive. All 3 cases reported clear at
3 years were found to have no tumour in the nodes examined but
of course small deposits could have been missed.
PACK (1959) quotes 20.0$ 5 year survivors with histologically
Table XXVIII
Fate of cases with operable nodes.
So treatment to nodes.
4 died within 3 years
2 died at 3 years 3 months
1 died 14 years later of other disease
Surgery to nodes*
3 died within 3 years
1 lost to follow up at 11 years (nodes negative)
Radiation.
Implant
5 died within 3 years
2 died at 3 years
1 died at 4 years
3 alive and well 13, 14
and 5 years after implant
Xray therapy
6 died within 3 years
1 died at 5 years
2 alive with disease at 3
and 4 years.
4 alive and well, 19, 18,
8 and 5 years after Xray
therapy.
2 died of other disease 1 and
2 years
1 lost to follow up at 3 years
1 lost to follow up at 1
year
1 alive and well 2 years after combined
implant and Xray therapy.
5 year survival
rate of determinate cases 3/ll 5/H
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positive nodes} LANE et al 20$ and PANATOTIS et al 13#.
More radical surgery to the extent of major exarticulation
has been recommended by PACK (1956) principally as the
treatment of choice in oases with primaries on the extremities
but the results he quotes for interacapulo thoracic amputation,
hip disarticulation, and heraipelveotoray do not lend themselves
to 5 year appraisal* Of 69 cases of melanoma treated in this
fashion 22 were alive but only 4 were alive at 5 years. It is
not stated how many were treated prior%to 1951 ^or reporting
in 1956. PACK and CRAMPTON (1961) report 3 cases of 20
melanomata surviving 5 or more years after a modified resection
of the shoulder girdle.
Table XVIII also details the fate of those whose nodes
were enlarged and were managed radiotherapeutically. If one
includes all those whose nodes were enlarged at the time of
referral to the radiotherapist (Stage B cases) a further table
can be compiled (Table XXVIII) which will include palliative
and no treatment oases as well as those whose original effective
treatment was radiotherapeutic or surgery followed by recurrence.
This shows that of 22 cases 8 survived over 5 years from the time
of their first treatment. Pour of these were proven by biopsy
„ or looal excision. This apparent doubling of the surgical rate
is based upon too few cases to be significant but may be
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suggestive enough to recommend that better results may he
obtained in Stage 11 cases by the judicious combination of
external radiation and either implantation or surgery for
remnants*
Local Recurrence.
"Satellite nodules" frequently appear around the site of
the excised primary. Whether this is attributable to direct
spread of a carcinogenic impulse along the dendrites of the
melanoblasts (PETERSEN et al, 1962) or lymphatic embolism in
the dermal lymphatics appears to be a purely pathological issue.
From the clinical aspect their importance lies in the
determination of the margin to be inoluded in eny treatment of
the primary. In so far as the satellite nodules appear much
more frequently in the proximal side of the excision (well
Illustrated in CADE, 1957) there appears to be more evidence in
favour of a lymphogenous origin for these recurrences than a
neurogenic or "oytocrine" (MASSON, 1948 and 1951)* This has
determined the surgical margin as being wider towards the
draining nodes than distally. The recommended margin in the
more recent articles (PETERSEN et al, 1962) has increased from
2.0 cm. to wide flap reconstructions of the whole of the skin on
the medial side of the thigh. However (HICKS et al, 1955) in a
small series have been much less radical, modifying the skin
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removal according to the site and availability of reconstructive
tissue apparently without increasing the incidence of
recurrence around the graft. VOGLER et al (1958) claimed only
3.0# local recurrence in 171 treated cases 95 of which had been
observed over 5 years.
Two points are made here for discussion later. First,
local recurrence is much more common following surgery than
irradiation (Table XXVII). Second, satellite nodules are rarely
seen around the untouched primary tumour. This may reflect a
fundamental concept in the behaviour of melanomata and possibly
malignant tumoursin general.
The confinement of a crop of nodules to an extremity
appears to lend itself to a purely local and radical attempt at
cure. It was on such cases that PACK (1956) and PACK and
CRAMPTON (1961) performed the more radical operations reported
above so that it is not surprising that the results were
disappointing. However where the salvage was so poor it becomes
difficult to justify the crippling which these procedures entail.
In an effort to save the limb yet confine treatment to the
known metastases and hence apply more radical measures, perfusion
techniques have been more commonly used in melanoma than other
malignancies. IRVINE, NOON and BARNSTABLE (1962) have
PiSt 3» A massive primary melanoma on the shoulder arising 3 years
prior to presentation with spread to the axilla only and one out¬
lying subcutaneous nodule over the right costal margin. No "satellite
nodules"around the primary.
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reported a small series of 16 cases of whom only 4 showed any
response and 2 died of the effects of treatment. The technique
was used as a MprophylacticH measure at the time of excision of
the primary in 5 oases and the results are more promising in
that all 5 remained alive and well for an average of 12 months.
No results of perfusion are available in the present study as
the procedure only heoame widely known after the close of the
series.
The Timing of Haematogenoua Spread.
The question of the time of release of the cells from
the primary site into the blood stream becomes of paramount
importance in the planning of any attempt at radical treatment
since it is this more than any local spread which will bring
about the death of the patient.
Primary tumours with histories of obvious malignant change
3 years prior to reporting (figure 3) have been found with one
solitary outlying suboutaneous nodule remote from the primary
and its nodes. Other patients report with lesions probably less
than a month old and apparently free of disease elsewhere, only
to produce widespread metastases shortly after what was thought
to be adequate surgical treatment. The swing away from surgery
on this account in Germany has already been mentioned.
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Zf this clinical impression is not correct then melanoma
is a completely unpredictable disease with blood borne cells
escaping from its inception and logically although unethically
and inhumanly the patient who reports with an early tumour
should have the minimum treatment and a completely pessimistic
outlook on his future adopted. This policy of nihilism has been
voiced (BLOODGOOD, 1922). If it is correct two explanations
for this behaviour are available. Either metastatic deposits
are sown at the time of surgery in a far higher proportion or
with a higher growth potential than other tumours or the
presence of a clinically obvious deposit of tumour exerts an
inhibiting influence upon the growth of seeded cells. Evidence
for the latter theory in animals with transplantable melanotic
tumours exists in the papers of SCHATTEH (1958) and
van den BRENK (196I). The former paper excludes experimentally
the effect of the strain of surgery on the appearance of lung
metastases as a factor in producing the results. Schatten took
D.B.A. mice and inoculated s91 melanoma and DBA sarcoma 49 into
one hind leg. He divided the successful tumour takes into 3
groups one of which was kept as a control. Of the other two
one had the tumour bearing leg amputated and the other had the
opposite leg amputated. The animals were all sacrificed at the
same time. All the animals which had the primary tumour removed
before death showed lung metastases in greater numbers and of a
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larger size than the other two groups. A subsidiary study
sacrificing animals one week apart showed that the pulmonary
metastases in the animals which had the primary tumour removed
were increasing significantly in number and size while in
those which retained the primary or had the opposite leg
amputated the pulmonary metastases were not actively growing
as measured by the difference in multiplicity and volume over
one week. Van den Brenk's experiment showed that it was much
more difficult to get two tumours to take in animals unless
they had been previously irradiated.
The immunological aspects of tumour control are not so
clearly understood with spontaneous tumours which are more
comparable with the situation in man but the experiments
quoted would explain the "lighting up" of tumour activity
following removal of a clinically obvious foous of melanoma.
Ethically it is not practicable to transfer the experiment to
human work with full control of the factors involved. The
prohibition of biopsy would mitigate against histological
confirmation until autopsy which is scarcely possible.
Spontaneous disappearance of disseminated metastases
occurs too frequently to be dismissed lightly. Host series
of any size contain one quoted case. In addition in 2.1# of
patients in this series the primary was never found and in
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other patients the site of presentation of enlarged nodes was
the only clue as to the region Involved. Subsequent excision
of clinically innocent naevi proved thera to be the primary, or
the patient gave a history suggestive of malignant change in a
lentigine which disappeared of its own accord. In such oases
when did spread occur? What change either in the tumour or in
the patient*s metabolic or hormonal state occasioned the
cessation of growth or even its complete healing at one site
while at another, cells persisted to grow again later or even
continued to grow while the parent tumour was being absorbed.
Pure speculation might suggest that the metastases inhibited the
primary, reversing the usual procedure. The converse occasion
when removal of the primary is followed by regression of the
metastases has not been reported in melanoma as it has with
carcinoma of the kidney and some ovarian neoplasms.
Treatment of Haematogenous Metastases.
Once deposits of tumour become evident remote from the
primary and its immediate drainage area, no cure is possible as
the presumption that any blood borne focus is not solitary is
much stronger than for other neoplasms such as hypernephroma.
Dissemination in this fashion is usually followed by an early
death with widespread melanotio tumours and in rare oases
melanosis. If the metastatic focus appears long after the
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treatment of the primary the potentiality for growth of that
particular melanoma in that particular patient may he low.
If so a solitary nodule may he the only sign of failure for
several years and it hehoves the medical attendant to treat
it locally and radically. As these deposits are almost always
on the trunk or in an internal organ perfusion becomes more
hazardous or impossible. Infusion with a general cytotoxic
agent is not without hazards of its own. Side effeots are
serious and uncomfortable, ranging from marrow aplasia to
alopecia, nausea and vomiting. Local and "radical" treatment
in the sense that the treatment is designed to eradicate the
disease without recurrences as far as possible, could be
exclsional or radiotherapeutic. Deposits on the skin are
surgically accessible and easily dealt with but affected
internal organs entail risky exposures and particularly in
brain metastases excision may seriously impair the patient's
functional integrity.
Radiation therapy, particularly external radiation entails
none of the risks of surgery but has been held to be a less sure
mode of treatment and to carry risks of its own. Table XXI
displays the respective methods and their results. It will be
seen that Xray therapy and radioactive implantation are not
inferior in prolonging life and are at least as effective as
surgery in alleviating symptoms.
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The risks associated with radiation are reputed to he
the supervention of oedema in a closed space such as the
skull, spinal canal or mediastinum and necrosis of the tumour
or the surrounding tissues. Oedema in a tumour is caused by
breakdown products of the dying cells. If this is the case
the tumour has responded and will shrink. If the rate of
shrinkage is the same or greater than the rate of accumulation
of fluid no serious disturbance will result* If the tumour
does not respond no breakdown products will be available to
cause oedema. The only net swelling occurs when the radiation
is not given sufficiently fast to cause rapid shrinkage. It
is therefore more logical to give large dose fractions - in
fact single doses or at most 2 to 3 doses spaced at weekly to
fortnightly intervals than to space small increments at more
frequent intervals. This policy has been used in intracranial
metastases on several occasions without exacerbation of
symptoms and signs. In all cases so far a prompt, if sometimes
short-lived, improvement was obtained. Cerebral metastases
appeared to be more responsive than subcutaneous deposits.
Where surgery was used on supposed solitary metastases in the
brain, both patients died with further cerebral involvement.
Neorosis of the tumour is of course inevitable with any
successful treatment. In surgically excised specimens it occurs
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after removal from the patient and oooaslon? no ham* With
radiation or chemotherapy the neorotio material is left
in situ* If erosion of a vital organ or blood vessel has
occurred this may precipitate a terminal event but this would
appear to have been inevitable at an eerly date without
treatment* No such terminal event was reoorded in this series
but one post mortem revealed a cerebro vascular accident in a
young woman who was not suspected of having cerebral metastases*
Necrosis of the surrounding tissues is acceptable if a radical
cure is hoped for but should be avoided in palllatlvely
treated oases*
Cfremotfcerqpr*
Fire oases showed some response to oytotoxlo agents*
These are listed in Table XX* Only the nitrogen mustard group
of drugs showed any promise In the control of the tumour. The
most dramatic response was obtained with cyolophosphanide
("ENDOXAN", "CYTOXAN") in a large single dose intravenously
(40 mgm per kilo body weight)* Subsequent experience has
confirmed that this appears to be the moet effeotive way of
administration* Not only wae it the most effeotive drug used
but the marrow depression associated with it affected only the
Leuoocytes to any great degree and that only temporarily*
Thrombocytes were but little affected* White cell counts of
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200 - approximately 2 weeks after injection usually recover
to normal within a further week without supportive therapy.
Alopecia is distressing at first since it occurs in ahout
80# of cases hut most patients accept this eventually.
Subsequent regrowth of hair is strong and well established
in 3 months.
Phenyl alanine mustard ("XELPHALAMn) was not available
during the period under review but has been extensively
reported as the most effective agent so far available.
Hormonal Treatment.
Factors suspected of indicating a hormonal dependency
in melanoma are - 1. The paucity of prepubertal cases,
2. the apparent association with pregnanoy, 3. the occasional
case of spontaneous regression which might be associated with
alterations of the endoorine status, 4. the isolation of a
melanocyte stimulating factor from the pituitary related to the
increase in pigmentation during pregnancy, 5» the hormonal
control of pigmentation and pigmentary cells in animals,
6. the slightly better results in women. In an attempt to
control disseminated melanoma manipulations of the hormone
balance were tried in 3 females and 2 males (Table XXIII).
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Although the menopause in one of the females was a
natural one and therefore should not striotly he included, the
regression at this time was so dramatic and the association
with endoorine alteration so clear cut that she has been
included under this category. Therapeutic ovarian ablation
has not been tried in a sufficient number of cases as a single
method of treatment to come to any conclusion about its
efficacy (CADE, 1957). "Prophylactic11 sterilisation in view
of the previous findings on pregnancy has no place in the
management of the disease.
In males the two cases included were not encouraging
and until clearer evidence is available on the dependence of
the tumour on male hormone no recommendation can be made as
to the value of orchidectony. Hypophysectomy is associated
with so many sequelae that it would have to produce much
better results to form a regular part of the therapeutic
armamentarium.
The Survival of Metastatic and Recurrent Cases.
Mention has already been made of measurement of the
effect of treatment by using the period between first treatment
and the reappearance of disease as a yard stick. Table XIX is
self explanatory. It is obviously possible to check the
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progress of the melanoma even in recurrent cases. Prolonged
survivals are achieved by both radical methods of treatment
but it must be remembered that these are only truly effective
when the deposit is a solitaiy one* Blood borne dissemination
is normally associated with rapid deterioration but palliation
of distressing symptoms is still possible.
The Duration of Life in Dead Cases.
Individual oases of malignant melanoma may show quiescence
for many years before reactivation, recurrence and death. This
appears to be mora common if the prime therapy is radiation
although this may be biassed by the shorter overall observation
period available for the surgical cases. However a one third
advantage would require a considerable improvement in the whole
group to equal it. Reference is made again to the work of
SCHATTE2J (1958) to account for this.
If radiation can curtail the aotivity of a melanomatoua
tumour as it seems able to do, but leaves a sufficient amount
of immunologically competent material which is not capable of
reproduction it may restrain metastases which have already
seeded. Although this may be commendable it cannot be denied
that the surest method of cure is still surgical excision of
all the disease. The difficulty arises in ascertaining if all
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the disease is excisable, since there is, as yet, no available
test which is universally applicable.
Response to irradiation.
Radioresistanoe is a relative term and not an absolute
description. It is measured by recording the behaviour of a
tumour following irradiation. One which shrinks rapidly is
radio responsive. One which persists or grows during irradiation
is radioresistant. However the shrinkage of an irradiated mass
is to some extent dependent on the division rate of the oells
slnoe damage to the cellular metabolism may not be evident until
it attempts division. Therefore a rapidly multiplying tissue
under normal circumstances will shrink Just as rapidly while a
slower rate of division will be associated with a much
diminished rate of regression. This phenomenon is seat daily in
radiotherapeutic departments. The fact that a basal cell
carcinoma apparently persists in an irradiated area for 3 months
does not necessarily mean that the lesion is recurrent although
the pathologist may report persistent tumour if the piece is
removed. All that is being seen are the oells whioh have not
divided sinoe radiation was administered. This tenet may or may
not be applicable to malignant melanoma.
If, as MASSON (1948 and 1951) suggests, the preoeding
Pig. 4a. Recurrence immediately below the skin surface shortly-
after block dissection.
Pig. 4t>. The same area after 4»500 rads. peak dose in 4 weeks. The
lesions have increased in size and number.
Pig, 4c, Six months after treatment there is an increased pigmentation
visible on the face, below the mid humerus and especially in the Left
neck where the radiation field is outlined by melanin.
Fig, 4<i* Close up of left neck showing that many of the deposits
are not associated with palppble nodules.
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naevus is composed of an epithelial and a nervous element the
melanoma may have a dual type of malignancy. The rapidly
dividing epithelial cells may be destroyed by radiation while
the more slowly progressing neurogenic tissue may persist.
The responsiveness of the tumour hs measured clinically would
therefore depend upon the proportions of each tissue within it.
The metastatic deposits would be likewise composed of both
types of cell although histologically they may be indistinguish¬
able. It is also possible that the neural elements have the
capacity to stimulate the local epithelial melanoblasts into
uncontrolled growth. Such a neoplasm would be ideally adapted
for metastatic spread since it not only makes use of the
materials in its nidus but the cellular population as well.
Cure by any means would be rare. Figure 4 illustrates a case
which recently reported to the centre in whom adequate surgioal
treatment including block disseotion was followed by rapid
local recurrence (4a) which proved completely radioresistant
(4b) and indeed showed more pigmentation in the irradiated area
than elsewhere. The wide spread dissemination which subsequently
ocourred was associated with melanurla and pigmentation of
apparently normal skin and this was more marked in exposed
regions (4<>). The metastatic deposits took the form of local
increase in this pigmentation without nodule formation (4d)
although section of one of these showed malignant melanoblasts
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in the dermis. This widespread stimulation may be a hormonal
effeot of the tumour cells but it is the only example in whioh
radiation was shown to exacerbate the disease in the area
treated.
Persistence of a nodule in a treated area is much more
common but in several instances in the series subsequent
excision was performed quite locally. In the one case which is
recorded as no response to a high dose implant the pathologist
could find no tumour in the excised speoimen although a pre-
treatment biopsy had Bhown melanoma.
Theoretically all cells are equally likely to be damaged
by ionising radiation under fully oxygenated conditions. The
faotors, apart from tumour type, which are usually quoted as
affecting radio-sensitivity, such as previous surgery or
radiation, site, infection and fibrosis all act through the
intermediary of the blood supply to the part to reduce the
oxygen tension within the tumour cell. It follows that if this
is equalised the cells will be equally damaged and the division
rate will determine the tissue destruction. If the number of
viable tumour cells can be reduced below an as yet undetermined
minimum the natural defences of the body will be able to complete
the onoolytlo process. It is not always easy to equalise the
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oxygen tension in tumour cells and normal tissues but
encouraging results have been reported by CHURCHILL-DAVIDSON
et al (1955) and MADIGAN, (1962) who have increased tumour
resolution following radiotherapy by exposing the patient to
high ambient pressures of oxygen during treatment. Melanomata
are reported in animals at least to have a relatively low
oxygen consumption (BURK et al, 1948). This has been
Interpreted as a disturbance of the rationoxidised to reduced
cytochrome oxidase* Paraphenylenediamine has been reported to
increase the oxygen consumption of Harding-Passey, Cloudman
S 9^ and Algire S 914 melanomata but the toxicity of this
substance is such as to preclude its use in human tumours.
The significance of the findings as regards the reported
radioresistance of these tumours has not yet been established.
SUGIURA (1948) came to the conclusion that animal
melanomata were "extremely resistant to radiation" but admits
that definite inferences from his data are questionable. The
dosage for radon tube Implantation was given in skin erythema
doses, the tubes contained a variable quantity of radon and
the mice were not standardised as regards age and size*
H.A.S. van den BRENK has kindly lent Illustrations from
unpublished work on the radiosensitivity of experimental
melanoma which completely contradicts Sugiura's finding.
Fig* 5* (couttesy, Dr. H.fi.S. van den Brenk). Harding-Passey mouse melanoma
transplanted in Algire transparent chambers in CBA mice.
1. and 2. t Unirradiated transplant at 24 hours (l) and 5 days (2). (x 85)
3. * Migrating melanoma cells at the border of the transplant at 48 hours, (x 20(i
4. 1 Vascular!sation of the transplant by host vessels at 4 days, (x 85)
Pig# 5- (Cont.) Chamber implanted with two fragments of the same tumour,
one of which (B) received 400 rads. Co rays in vitro immediately
preceding implantation. Photographs show progressive growth of the
unirradiated fragment (A) and regression and degeneration of the irradiated
portion (B) (x 8)
5.i day 7» 6. * day 10. 7. « day 13. 8. : day 17.
Fig. 5, (eont.) 9. and 10. continue the previous sequence at day 27 and 45
showing the engulfing of the irradiated transplant by the growth of the
control portion, (x 8).
11. i The edge of the unirradiated specimen showing melanoma cell migration
at day 6. (x 40). .
12. t The edge of the irradiated pieoe at day 6. No migration is visible, (x 40)
13. « As in 12. 4 days later showing pseudomigration due to degenerated
cells and melanin, (x 40).
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Figure 5 shows two inocula of Harding-Passey melanoma in a
mouse back chamber* One half of the inoculum received 400 rads
in air before implantation. It is obvious that its capacity
to produce a tumour was markedly impaired* The edge of the
tumours shown in higher magnification contrasts the active
migration into the surrounding tissues of the unirradiated
specimen with the smooth edge of the irradiated side* The
later appearance of a stippled edge is due not to active cells
but free melanin granules released from the degenerating
neoplasm*
In the present series measurements of the tumour were
available before and after treatment in all cases in which
radiation response is recorded. Shrinkage of a tumour mass
during or after radiation therapy is a reasonably good
indication that some alteration has taken place but the
presence of oedema within the mass from any cause prior to
treatment makes this assessment difficult to appraise. Since
surgery is frequently followed by oedema it follows that the
only response which can be relied upon is one in which no
incisional attack has been made upon the tumour or its
surroundings. Infection is similarly a bete noir since it not
only causes oedema but also interferes with radiosensitivity.
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The response to radiation was strikingly high in implanted
lesions. This may be related to the local dosage which is
appreciably higher than for external therapy. Another factor
to be considered is the continuity of irradiation with
radioactive material. SITTER (1956 and 1959) has obtained
good results with radium moulds. Recent reports (HALE, 1961)
have suggested a periodicity of mitotic cycle in neoplasms which
may be related to a variation in radiosensitivity whioh
continuous radiation may be better able to utilise than dis¬
continuous Xray therapy. Confirmation of this work is awaited
with interest.
146 cases of I67 showed some measurable effect of
radiation although of these 53 showed an incomplete response in
that the tumour did not disappear entirely or recurred within
the treatment area after a tumour free period.
Radionecrosis.
In the effort to force a response it is not surprising
that dosages were carried to radionecrotic levels. This was
commoner with interstitial implantation although subcutaneous
fibrosis and restriction of shoulder movement following high
doses to axillary nodes were noted in later years with Xray
therapy. Since some disability as the result of treatment was
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apparent although in most eases this was eorreotahle hy excision
and graft, the survival of these cases should show some
improvement over the remainder if the risk of radionecrosis is
to be an acceptable one. It would appear that this is indeed
the case although the numbers are too small to detect statistical
significance.
Recurrence in a Treated Area.
Recurrence in the treated area or it s immediate vicinity
following surgery occurred in 50%* Only 23 cases irradiated
showed recrudescence of tumour following clearing (13.8^).
However it is only fair to include among the recurrences those
where incomplete olearing had been achieved which leads to a
44# "recurrence rate". It has previously been pointed out that
some of the persistent tumours did not in fact show malignant
cells under the microscope and even of those who did.,not all
would have been able to reproduce. It is further pointed out
that while radiation response is seriously interfered with by
surgery the converse does not necessarily hold true. Many
remnants can be removed locally without apparent ill effects.
Bad Result.
10 oases died of melanoma over 10 years after the first
treatment. As there were only 30 survivors at 10 years this
represents a further 33 1/21% attrition. Of 64 5 year survivors
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22 died after this point. This runs counter to BLOCK and
HARTWELL'S (1961) assertion that few oases die after 5 years
and renders meaningless the 5 year "cure" rates published Tjy
PACK (1959) and many other authors, since some at least are
harbouring latent disease. It is for this reason that no
attempt has been made in this study to relate the figures to
"cure". Any oase dying of disease at a later stage is noted
as being alive with disease at the point of assessment.
"Other diseases" causing death were carcinoma of the
duodenum, carcinoma of the larynx, eerebro vascular accident
proven at post mortem, post operative broncho-pneumonia, death
during anaesthetic, and congestive cardiac failure. Several
oases were clinically diagnosed as cerebral tumour or cerebro
vascular disease. In view of the high probability of their
death being due to metastases they have been counted as dying
of melanoma unless post mortem evidence for such a cause of
death was lacking. Many of the cases lost to follow up were in
fact ill at their last visit or were reported to be ill by their
local medical attendant. If all cases lost to follow up are
counted as dead the 10 year survival rate beoomes 30.656, the
5 year survival rate, 44.C# and the 3 year rate 55.656
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Conclusions.
The first and basic result of this study is to diow that
radiation is by no means useless in malignant melanoma* Even
as a palliative it appears to increase survival and certainly
is a safer and more sure way of relieving local symptoms than
any chemotherapeutio agent yet tried extensively. The fact
that the established disease can respond in the great majority
of cases has been obscured by the relative minority of spectaoular
failures.
f
In view of this and the disappointing results of surgery at
least in certain situations» e.g. trunk and foot lesions it is
perhaps worthwhile trying it in an attempt to improve the results
in the elderly, unfit and more advanoed case in whom the prognosis
evon with - or perhaps especially with - radical surgery is poor.
It would appear that any case with obviously involved nodes
is beyond help by surgery alone. DICKSON (1958) has shown the
improvement which post-operative radiation can achieve in early
cases. It is postulated that in the advanoed case intensive
radiation may prolong the patient*s life and preserve the
functional integrity of his extremities with a better chance of
so doing if surgery is not embarked upon*
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The natural corollary is to advance this postulate
further to the early case in whom nodes have not appeared*
Difficulty is immediately experienced with the histological
proof of the nature of the lesion since incisional biopsy has
been shown to alter the prognosis for the worse. Local
excisional biopsy removes the lesion for pathologioal confirm¬
ation and post operative radiation can then be administered.
This scheme is followed in Norway (HITTER, 1956* 1959*
EFSfCIND and HITTER, 1962). However the problem of the draining
nodes must be considered sinoe in at least a proportion of cases
the tumour appears to be confined to the primary site and the
nodes. Radical block dissection in this series has been
disappointing. The operation Is not without mortality although
this is small end becoming smaller. The morbidity is not
negligible. Extending the operation to deal with further
extensions into the internal mamm&ry chain, iliac or para aortio
nodes increases both these disadvantages without promising much
more in the way of salvage. Although subsequent radiation appears
to be beneficial it cannot be used in these circumstances under
ideal radiobiological conditions. It also cannot be denied that
some cases derive no benefit from its use. The problem therefore
is to seleot the best method or combination to suit eaoh case*
McWHlRTER has advocated preoperative radiation for any
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clinical -thyroid carcinoma so that the few who are extremely
radio responsive may he selected for radical wide field
treatment to the neck and lungs. Ho biopsy is performed, until
the response has been assessed for fear of confusing the
appraisal. Equally in responsive cases, biopsy must follow
clinical examination without delay since the tumour may
disappear entirely. If this scheme is acceptable for thyroid
tumourB there is an equal claim for its employment in malignant
melanoma although the stricture upon the time of biopsy is by
no means as rigid.
The following policy is put forward as a practical regime
for dealing with the disease. A clinical diagnosis of malignant
melanoma is more frequently correct than not (HICKS et al, 1955*
MILTON and JELIHOVSKT, I962). Once a firm diagnosis has been
made, careful measurements and photographs are taken. A single
dose of 1,000 rads is given to the tumour and a 2.0 cm. margin
of normal skin using superficial Xray therapy for thinner
tumours and correspondingly greater half value layers for those
in whom the tumour is too thick to allow 30$ of the dose at the
estimated base. This dosage can be delivered without delay, no
waiting lists are involved and the promptness of treatment can
only be beneficial. Ho biopsy is taken. At the end of one week
a further measurement and photograph are recorded and a second
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dose is given* If a response has been obtained by objective
measurement it should be permissible at this stage to take a
biopsy and proceed to a third dose one week later. If no
response is noted at the end of the first week no further
radiation should be administered after the second dose* Even
in such oases some benefit can be expected from the radiation
in sterilising the better oxygenated cells at the periphery of
the tumour or around blood vessels may be expected* It is
surely from this area that the dissemination of cells during
surgery must come* The radiation may therefore assist in
preventing or delaying the appearance of blood borne metastases*
Vide excision removing all the irradiated tissue should follow*
Block dissection in continuity if this is feasible or delayed
block disseotion should be performed* Vhether this should be
followed by post operative therapy or not is doubtful since the
tumour has been shown to be radioresistant but if tumour is
found in the draining nodes it may serve some purpose after
surgery.
A responding case should be given a course of radiation
to the draining nodes after a delay of 4 weeks since delayed
treatment of the nodes has been shown to produce better results
than immediate dissection (PETERSEN et al) presumably because
tumour emboli released at the time of operation into the
lymphatics have time to reach the node station, PANAYOTIS
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et al, 1962 have shown this effect to "be invalid for oases
without nodal involvement hut their figures reveal a slight
improvement in those whose nodes are reported to contain tumour*
Equally the same considerations should he applicable to
radiation although irradiation in continuity since It will
involve a change in the half value layer is seldom possible
unless the primary lies immediately over the drainage field* In
that event a risk of radloneorosls must he accepted if conventional
voltage Xray therapy is all that is available. However the use of
megavoltage equipment or telecobalt or teleoaesium will allow
some skin sparing while achieving adequate depth dosage with a
single field and this factor may prevent subsequent necrosis* The
dosage for irradiation of a clinically uninvolved field should be
oarried to skin tolerance for conventional voltages or subcutaneous
or underlying tissue tolerance for supervoltage equipment* The
3 dose technique used for the primary is not applicable to wide
fields placed over major joints, the abdomen or mediastinum.
The biopsy taken after the second treatment should not alter
the prognosis In cases who respond and it is not performed in
those who do not* It will probably show the effects of radiation
but these are not sufficiently severe to obscure the difference
between a melanoma and the more benign conditions which may be
confused with it. It will probably not be possible one week
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after a large dose of radiation to distinguish between juvenile
melanoma, superficial melanooarcinoma and invasive melanoma but
in the main these are clinically doubtful lesions and a firm
olinioal diagnosis Is unlikely.
Where doubt exists as to the dia&iosis wide excision is
still the treatment of choice if the lesion is a naevus in the
process of alteration. Where even this point is not clear local
excision will allow the pathologist to use proper facilities and
due consideration to come to a diagnosis without materially
affecting the prognosis if the appropriate treatment, which may¬
be radlotherapeutic, follows. This is the type of case which
does best with surgery. Zt is the clinically obvious ulcerated
lesion which produces the worst results.
For the case which has already produoed regional nodes no
delay should be allowed before administering radiotherapy to all
the involved regions. Xt is in this case that barotherapy may
have a part to play although the fractionation and intervals to
achieve maximum tumour resolution with ^minimum tissue disturbance
have not been finally settled.
If nodes persist in a drainage area after irradiation
surgical excision may still be possible. Occasionally the
81.
radiation changes in the skin and subcutaneous tissues or the
situation of the residuum is such as to render the case
inoperable. The implantation of local radioactive sources has
much to recommend it in these ciroumstances since it confines
further high dosage to the immediate vicinity of the tumour,
and it utilises continuous irradiation which may be an
advantage. Implantation as the initial treatment theoretically
has the same disadvantages as surgery in disturbing the tumour
bed and disseminating tumour. Certainly the few cases presented
in this review have done better with Xray therapy first.
The risk of radionecrosis in suoh a case is of course high
but it is felt that the possible benefits of this mode of
treatment make this hazard acceptable.
The use of continuous external radiation for the primary
tumour in the form of a radioactive mould would allow full
utilisation of the effect previously mentioned but it is not
such a decisive means of high dose Irradiation and involves a
delay between diagnosis and the institution of treatment. Much
will depend upon the further investigations into P 32 uptake
during the cell cycle and the prediction of radio sensitivity.
Persistent disease in the primary area has been safely
Pig. 6a. Malignant melanoma developing in an area of melanosis on the sole
of the foot. Before treat ant.
Pig. 6b. The same area 6 months after 3 * 800 rads and curettage of a
residual nodule. The dose was reduced because of the poor circulation in the foe
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curetted with complete healing in two cases one of which is
illustrated in Figure 6. Both were elderly patients in poor '
general condition and presented aftor the instigation of this
policy.
It is hoped that this proposal will go a long way to
meeting the need, expressed editorially in the LANCET (1962),
for "a line of therapy which is generally acceptable and
widely applicable" although general acceptance would be a lot
to ask without considerably more than the mere proposal. At
least it is hoped that radiotherapy will be used more
frequently to palliate advanced cases since therapeutic nihilism
has resulted in 33# of Stage III cases being offered no
treatment in one review (HEISE and KREMENTZ, 1961).
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